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ABSTRACT 
Psychostimulant drug effects on electrophysiological indices of early stage 
sensory processing and rodent performance of a visual signal detection task 
 
Rachel Lynn Navarra 
 
Supervisor: Barry Waterhouse, Ph.D. 
 
Methylphenidate (MPH) is a psychostimulant drug used clinically to treat 
ADHD and off-label as a performance enhancing agent in healthy individuals.  
MPH enhances catecholamine transmission via blockade of norepinephrine (NE) 
and dopamine (DA) reuptake transporters.  However, it is unclear how blockade 
of catecholamine reuptake impacts neural circuits responsible for cognitive and 
sensorimotor function to result in performance enhancement.  Optimal detection 
of sensory information is critical for cognitive and motor actions and overall 
performance enhancement may significantly rely on improvements in processing 
incoming sensory stimuli.  The locus coeruleus (LC)-NE system regulates state 
dependent transmission of sensory signals.  The rat dorsal lateral geniculate 
nucleus (dLGN) is the primary thalamic relay for visual information from the retina 
to the visual cortex and output from the LC-NE system facilitates dLGN neuronal 
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responses to afferent input.  Selective attention to incoming stimuli also 
enhances LGN responsiveness during successful performance of sensory-
guided goal-directed behaviors.  The hypothesis tested in the current work is that 
psychostimulant agents, such as MPH, that increase NE neurotransmission and 
improve attention should enhance stimulus-evoked neuronal responsiveness to 
visual stimuli within the rat dLGN and behavioral outcomes during performance 
of a visual signal detection task.   
Initial electrophysiological experiments demonstrated MPH enhancement 
of dLGN neuronal responses to light stimuli in the anesthetized rat.  To 
investigate the relevance of these findings to dynamic conditions that exist in 
waking animals, MPH was evaluated for its potential to alter dLGN 
responsiveness and behavioral outcomes during performance of a visual signal 
detection task.  Rats were trained to indicate by lever press whether light stimuli 
were detected.  MPH enhanced properties of light-evoked activity within 
individual neurons, ensembles of neurons, and visually-evoked potentials in 
response to light stimuli that guided performance within the task.  MPH also 
improved reaction times to make correct responses during task performance.  
Further, it was demonstrated by immunostaining that catecholaminergic 
innervation to the dLGN is solely noradrenergic.  This work suggests that MPH, 
acting via noradrenergic mechanisms, can substantially impact early stage 
sensory signal processing and subsequent behavioral outcomes.  Sensory 
enhancement may be a significant component of psychostimulant-induced 
performance enhancement in ADHD patients and healthy individuals.  
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CHAPTER 1 
INTRODUCTION 
 
Methylphenidate 
Methylphenidate (MPH; Ritalin ®) is a prescription psychostimulant drug 
used primarily as the first line of therapy in the treatment of attention deficit 
hyperactivity disorder (ADHD), a common neurodevelopmental disorder 
characterized by inattention, hyperactivity, and impulsive behavior (Arnsten, 
2006b, Levy, 2014, Weyandt et al., 2014).  MPH was synthesized by Leandro 
Panizzon in 1944 and first marketed by Ciba-Geigy Pharmaceutical Company 
(now Novartis Pharmaceuticals Corporation) in 1955 for a range of indications; 
including fatigue, lethargy, depression, and cognitive impairment (Lange et al., 
2010).  However, MPH is currently only approved for ADHD and narcolepsy 
(www.fda.gov, 2013).  MPH is also frequently used off-label as a performance 
enhancing drug in healthy individuals without ADHD (Cakic, 2009, Franke et al., 
2014, Repantis et al., 2010, Sahakian and Morein-Zamir, 2015).  Despite the 
widespread prescription and off-label use of MPH and decades of clinical and 
preclinical research investigating the actions of MPH, the precise mechanisms 
through which psychostimulant agents such as MPH regulate neural circuit 
functions that govern cognitive and sensorimotor processes resulting in 
performance enhancement are poorly understood.   
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Biochemically, MPH is an amphetamine derivative that occupies 
catecholamine transporters and blocks the reuptake and removal of  dopamine 
(DA) and norepinephrine (NE) from the extracellular space (Han and Gu, 2006, 
Hannestad et al., 2010, Spencer et al., 2006, Volkow et al., 2002).  Reuptake 
transporters are located at sites of neurotransmitter release on axons and serve 
to terminate transmitter action by resorption back into the presynaptic cell for 
recycling or degradation (Torres et al., 2003).  Blockade of DA and NE 
transporters (DAT and NET, respectively) results in increased catecholamine 
neurotransmission throughout the brain (Bymaster et al., 2002, Kuczenski and 
Segal, 2001, Volkow et al., 2002).  Although MPH serves as an indirect agonist 
by increasing extracellular concentrations of NE and DA, the receptor-mediated 
mechanisms responsible for specific dimensions of improved cognitive function 
and the loci of these actions are an ongoing topic of discussion (Andrews and 
Lavin, 2006, Arnsten and Dudley, 2005, Gamo et al., 2010, Spencer et al., 2015, 
Wilens, 2008).   
  
Methylphenidate and clinical treatment of ADHD 
ADHD is a developmental psychiatric disorder that affects about 5 – 7% of 
the worldwide population (Polanczyk et al., 2007, Thomas et al., 2015).  Onset 
and diagnosis usually occurs within juvenile and adolescent populations; 
however, symptoms often continue to persist into adulthood (Semeijn et al., 
2016).  Hallmarks of ADHD include a triad of behavioral symptoms; 
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inattentiveness and/or hyperactivity and impulsivity that impair an individual’s 
ability to properly function across a range of social, academic, and occupational 
settings (Levy, 2014).  From this cluster of symptoms, three main subtypes of 
ADHD have been defined; predominantly inattentive, predominantly 
hyperactive/impulsive, and combined inattentive and hyperactive/impulsive.   
ADHD symptoms are thought to result from abnormal regulation or 
dysfunction of catecholaminergic neurotransmission within the prefrontal cortex 
(PFC) (Arnsten, 2006a, Arnsten and Rubia, 2012, Arnsten and Pliszka, 2011, 
Cortese, 2012, Shaw et al., 2007, Shaw et al., 2013, Tripp and Wickens, 2009).  
This hypothesis is strongly supported by the mechanisms of action through which 
drugs approved by the FDA for treatment of ADHD produce therapeutic effects.  
For example, psychostimulants, including MPH and amphetamine, are most 
commonly prescribed as first-line treatment and both drugs block reuptake of NE 
and DA.  An additional action of amphetamine is to increase DA release through 
DAT-mediated reverse transport (dela Pena et al., 2015, Espana and Jones, 
2013).  Atomoxetine is a non-stimulant ADHD medication that selectively blocks 
NE reuptake, although its selectivity for NET over DAT is dose dependent.  In 
areas of low DAT expression as compared to NET, such as the PFC, NET 
actually transports DA with a higher affinity than it does NE (Bymaster et al., 
2002, Carboni et al., 1990, Madras et al., 2005, Swanson et al., 2006).  Thus, in 
this case blockade of NET also prominently affects extracellular DA 
concentrations.  The efficacy of  noradrenergic alpha-2 receptor subtype 
agonists, such as guanfacine, in treating ADHD symptoms further supports a role 
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for dysfunction of catecholaminergic systems in ADHD (Arnsten and Pliszka, 
2011).   
Overall, the drugs used successfully to treat the symptoms of ADHD share 
in common the ability to increase catecholamine neurotransmission.  However, it 
is important to note that although hypoactive catecholamine function has been 
strongly implicated in ADHD pathology, the NE and DA systems both function 
optimally according to an inverted U-shaped curve (Arnsten and Pliszka, 2011, 
Robbins and Arnsten, 2009).  Either extreme, hypoactivity or hyperactivity within 
these systems could disrupt the delicate and necessary balance of operations 
resulting in suboptimal function.    
The PFC regulates higher order executive functions important for goal-
directed behavior, such as attention, impulse control, working memory, problem 
solving, motivation, and emotion  (Arnsten, 2006a, Arnsten and Rubia, 2012, 
Arnsten and Li, 2005, Arnsten and Pliszka, 2011, Berridge and Devilbiss, 2011).  
Given the importance of these PFC-driven functions in successfully 
accomplishing goal directed tasks, overall productivity, maintenance of social 
relationships, and quality of life require that neurotransmitter concentrations be 
appropriately balanced and maintained at optimal levels.   At clinically relevant 
low doses prescribed for ADHD, MPH preferentially enhances DA and NE within 
the PFC and these effects strongly correspond with improved cognitive function 
(Berridge and Devilbiss, 2011, Devilbiss and Berridge, 2008).  As such, it is likely 
that MPH-induced improvements in cognitive functions affected by ADHD are 
due to enhanced catecholaminergic neurotransmission within the PFC.  Indeed, 
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there has been a strong emphasis on identifying and dissociating the receptor-
mediated mechanisms underlying specific components of improved cognitive 
function following MPH administration.  For example, specific activation of NE 
alpha-1 receptors within the PFC facilitates both flexible and focused/sustained 
attention (Berridge et al., 2012, Berridge and Spencer, 2015, Lapiz and Morilak, 
2006, Spencer et al., 2015).  Additionally, stimulation of DA D1 receptors and 
post-synaptic NE alpha-2 receptors enhances, while NE alpha-1 receptor 
activation impairs, working memory (Andrews and Lavin, 2006, Arnsten and 
Dudley, 2005, Arnsten et al., 1996, Gamo et al., 2010, Spencer et al., 2015).   
Taken together, MPH affects a broad range of catecholaminergic receptor targets 
within a narrow range of doses to produce its comprehensive cognitive-
enhancing effects and there is still much to learn regarding further mechanisms 
regulating neural circuit functions of information processing and sensorimotor 
function.   
 
Methylphenidate use in healthy individuals 
 In addition to its FDA approved clinical indications for ADHD, MPH is 
popular among otherwise healthy individuals for its performance enhancing 
effects.  Off-label use of MPH benefits various aspects of academic, athletic, and 
social performance ranging from improved concentration to elevation of mood 
(Svetlov et al., 2007).  Because it offers advantages to such a broad range of 
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people and across all age groups, MPH is known as a “universal performance 
enhancer.”   
  
Cognitive enhancement 
One of the most intriguing properties of psychostimulant drugs like MPH is 
their ability to improve cognitive performance in non-ADHD individuals.  Off-label 
use of MPH for its pro-cognitive effects has become widespread and steadily 
continues to rise within academic circles and in a wide variety of occupational 
settings (Advokat and Scheithauer, 2013, Cakic, 2009, Franke et al., 2014, 
Greely et al., 2008, Linssen et al., 2014, Maher, 2008, Sahakian and Morein-
Zamir, 2015, Smith and Farah, 2011).  Academic “doping” with MPH is a 
common practice among students on college campuses and has also been self-
reported among research scientists and professors as a means of improving 
concentration and focus, while fighting fatigue (Maher, 2008, Sahakian and 
Morein-Zamir, 2007a).  Upon recent review, the most predominant and 
consistent effects of MPH observed in healthy individuals across cognitive 
domains of neuro-enhancement are improvements in working memory, speed of 
processing, verbal learning and memory, attention/vigilance, and problem solving 
(Linssen et al., 2014).  Understandably, in high pressure stressful environments 
such as college and scholastic institutions, increasing productivity and 
decreasing the need for sleep are highly desired effects towards promoting 
effective performance.     
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Beyond cognition towards overall performance enhancement  
 Off-label use of MPH by healthy individuals extends far beyond students 
cramming for exams.  Illicit use of psychostimulants traditionally used for 
treatment of ADHD is rampant among military personnel, night shift workers, first 
responders, and there is a huge trend for athletes to use psychostimulants as 
performance enhancing agents in sport (Ambrose et al., 2013, Deventer et al., 
2011, Hickey and Fricker, 1999, Lakhan and Kirchgessner, 2012, Maher, 2008, 
Sahakian and Morein-Zamir, 2007b).  Psychostimulant use among professional 
athletes has become so popular that major sports organizations such as Major 
League Baseball, National College Athletic Association, and the National Football 
League have formed strict policies banning psychostimulant use in players 
without an official diagnosis of ADHD and a filed therapeutic use exemption 
(TUE).  What has resulted is a dramatic increase of ADHD diagnoses in baseball 
players, so much so that baseball players have an unusually high prevalence of 
adult ADHD, 2-3 times over that of the general population (Lakhan and 
Kirchgessner, 2012).  Other organizations, such as the International Olympic 
Committee, have banned the use of psychostimulant drugs and TUEs altogether, 
regardless of whether or not an athlete is legitimately diagnosed with ADHD.  
Given the prevalence of MPH use as a performance enhancing agent, the 
neurobiological basis for the positive impact of psychostimulant drugs on athletic 
performance has not been elucidated. 
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Recreational Use 
In addition to general performance enhancing effects, MPH is also used 
recreationally as a party drug because it increases motor activity, promotes 
talkativeness, and elevates mood (Clemow and Walker, 2014, Maher, 2008).  
Self-reported positive reinforcing effects of MPH include a drug “rush” and 
stimulation according to a Drug Liking Visual Analog Scale (VAS) assessment 
and feelings of vigor, friendliness, elation, arousal, and positive mood were 
reported in a Profile of Mood State (POMS) assessment (Lile et al., 2010).  
According to Berridge and Arnsten (2013), MPH produces reinforcing effects by 
enhancing the brain’s natural arousal and reward circuits, resulting in increased 
energy and feelings of euphoria.  Illicit recreational use and the abuse potential of 
MPH are mainly attributed to elevated DA neurotransmission within subcortical 
areas responsible for regulating motivation, pleasure, and reward, such as the 
nucleus accumbens. However, the role of NE in regulating arousal and elevating 
mood cannot be discounted as contributing factors to the psychostimulant-
induced high (Berridge and Arnsten, 2013, Clemow and Walker, 2014).   It is 
important to note that therapeutically active low doses of MPH are behaviorally 
calming and cognitive enhancing in both ADHD and non-ADHD individuals, 
whereas illicit use generally occurs at much higher behaviorally activating and 
euphoria producing doses.  Further, while low doses of MPH preferentially 
increase catecholamine neurotransmission within the PFC, higher doses widely 
affect subcortical catecholamine neurotransmission in areas such as the nucleus 
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accumbens, ventral striatum, and amygdala (Berridge and Arnsten, 2013, 
Clemow and Walker, 2014).    
 
Health, legal, and ethical concerns   
MPH’s illicit use has raised significant health, legal, and ethical concerns.  
The misuse of MPH can be dangerous as individuals commonly self-administer 
at doses higher than therapeutically prescribed, whether intentionally or not.  
Health risks include sleep and appetite disturbances, cardiac function 
abnormalities, symptoms of mood disorders, drug interactions with other 
medications, and substance dependence (Klein-Schwartz, 2002, Lakhan and 
Kirchgessner, 2012, Martinez-Raga et al., 2013, Spiller et al., 2013).  
Unintentional overdoses present a vast range of neurological and cardiovascular 
symptoms including agitation, dizziness, restlessness, psychosis, seizures, 
tachycardia, hypertension, and chest pain.  From a developmental perspective, 
MPH can substantially influence ongoing maturation processes of the PFC when 
used by teens and college-age students (Urban and Gao, 2014).    
The Drug Enforcement Administration has declared MPH a Schedule II 
controlled substance because of its potential for abuse and dependence, a 
designation which makes off-label use and misuse of the drug illegal.  Illegal use 
includes prescription sharing, prescription misuse, or possession without a 
prescription.  In addition to off-label use in healthy individuals, ADHD patients 
that have been prescribed MPH also misuse the drug by diverting their 
prescriptions to healthy individuals or taking it at higher doses, more frequently 
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than prescribed, or to achieve a drug high (Clemow and Walker, 2014, Klein-
Schwartz, 2002).  Diversion of prescriptions, either by selling or giving the 
medication away creates an illegal marketplace for MPH.  Malingering, which is 
the feigning or exaggeration of ADHD symptoms to obtain unnecessary 
prescriptions or prescriptions of higher doses than necessary, is not only illegal 
itself, but further exacerbates the prevalence of off-label use and contributes to 
the illicit marketplace, creating further concern (Clemow and Walker, 2014, 
Svetlov et al., 2007).   
There are also obvious ethical concerns regarding the use of MPH as a 
performance enhancing agent to gain arguably unfair competitive mental and 
physical  advantages over their peers in academic settings and athletic contests 
(Advokat and Scheithauer, 2013, Bogle and Smith, 2009, Cakic, 2009, Forlini 
and Racine, 2009, Graf et al., 2014, Greely et al., 2008, Sahakian and Morein-
Zamir, 2007b, Sahakian and Morein-Zamir, 2015).  Despite the popularity of 
MPH for performance enhancement, the neurobiological basis for this overall 
effect is unknown.   
 
Desirability of MPH 
The off-label use and misuse of psychostimulants such as MPH extends 
far beyond their FDA-approved indication to improve cognition in ADHD 
individuals or their wake-promoting effects in regard to narcolepsy.  MPH is used 
as a pro-cognitive agent in healthy individuals, a performance enhancing agent in 
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athletes, and also recreationally for its euphoric effects.  Much work has focused 
on MPH actions in regions of the brain responsible for its pro-cognitive benefits 
and abuse potential; however, MPH’s actions in parallel networks of information 
processing have received less attention.  What other brain circuits and neural 
operations derive benefit from MPH’s actions and contribute to performance 
enhancement, including faster/better processing of incoming environmental 
stimuli and subsequent reaction to them?  Further understanding of MPH action 
throughout the brain may provide valuable information regarding the 
neurobiological basis of the desirability and motivation for otherwise healthy 
individuals to engage in off-label self-administration of psychostimulant drugs.   
 
Sensory Processing 
Sensory processing is an essential component of effective cognitive and 
motor function.  Optimal detection, discrimination, and coding of sensory 
information is critical for maintaining focus on task related stimuli, facilitating 
efficient behavioral responses to priority targets, and completing successful goal-
directed behaviors.  The ability to amplify neural representations of important 
sensory stimuli is crucial for these processes.  Interestingly, inappropriate 
regulation of sensory processing is a common feature of many neuropsychiatric 
disorders including ADHD (Cheung and Siu, 2009, Clince et al., 2016, Koziol and 
Budding, 2012, Lufi and Tzischinsky, 2014, Mangeot et al., 2001, Mazer, 2011, 
Pfeiffer et al., 2015).  Although limited, there have been reports demonstrating 
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the ability of psychostimulants to alter various dimensions of sensory processing 
(Drouin et al., 2006, Drouin et al., 2007, Hodzhev et al., 2012, Jonkman et al., 
1997, Korostenskaja et al., 2008, Ozdag et al., 2004), suggesting that modulation 
of sensory signal processing may be a significant component of the performance 
enhancing properties of these agents. 
 
Modulatory influences on sensory signal processing 
Modulation of sensory processing is critical for organisms to selectively 
filter competing incoming information and efficiently adjust behavioral responses 
within complex, dynamic environments.  At any given time, an overwhelming 
amount of information from the sensory surround is competing for the limited 
resources responsible for neural representation of high priority versus low priority 
stimuli.  Adaptive processing of incoming information occurs as a result of 
bottom-up influences, such as the perceived salience of an external stimulus, 
and top-down feedback mechanisms, such as knowledge or expectation (Kastner 
and Ungerleider, 2000, Mazer, 2011).  Although both bottom-up and top-down 
mechanisms are acknowledged, their interaction and convergence on early 
stages of sensory signal processing and how psychostimulants can impact these 
mechanisms has not been elucidated.     
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Bottom-up modulation of sensory processing 
Stimulus salience is the primary determinant for prioritizing the neural 
representation of incoming information in terms of bottom-up modulatory 
mechanisms (Kastner and Ungerleider, 2000, Treue, 2003).  Salience of an 
external stimulus is assigned according to the physical properties of the stimulus 
itself, rather than internal top-down factors that bias the processing of incoming 
stimuli according to organismal demands.  Stimuli with the most intense 
properties within the sensory surround, such as the brightest, loudest, or most 
novel are often highlighted by bottom-up mechanisms.  Discontinuity, or the 
difference of a stimulus compared to surrounding stimuli, is also a very strong 
factor in bottom-up processes and can trump the physical strength of competing 
stimuli (Kastner and Ungerleider, 2000, Treue, 2003).  For example, a small red 
flower stands out in a large field of green grass and a vertical line stands out 
easily among distractor diagonal lines.  Ultimately, competition for neural 
representation is modulated by a combination of bottom-up and top-down factors, 
so although the inherent salience of a stimulus according to physical properties 
plays a significant role in attracting sensory resources, internal factors such as 
attention and behavioral state will often further influence the allocation of sensory 
processing resources.   
 
Top-down regulation of sensory processing 
Attention is a top-down executive function required for maintaining focus 
and facilitating adaptive behavior through its modulatory effects on sensory 
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processing (Gilbert and Sigman, 2007, Kastner and Pinsk, 2004, Kastner and 
Ungerleider, 2000).  Selective attention enhances neural responses to attended 
stimuli as compared to when ignored (McAlonan et al., 2008, O'Connor et al., 
2002, Schneider, 2011, Schneider and Kastner, 2009).  In this way, salience of a  
preferred or task related stimulus is increased internally by priming neuronal 
receptiveness and decreasing perceptual sensitivity thresholds, or increasing 
discriminability, of important stimuli (Sundberg et al., 2012).  Candidate regions 
for exerting top-down influences include parietal, temporal, and frontal areas of 
the brain (Gilbert and Sigman, 2007, Kastner and Pinsk, 2004).  Specifically, the 
PFC, which governs executive functions, such as attention (Arnsten and Rubia, 
2012, Arnsten and Pliszka, 2011, Berridge and Devilbiss, 2011), has been 
identified for its role in the selection and maintenance of information that is 
behaviorally relevant (Rainer et al., 1998).  The PFC is essential in a variety of 
behavioral paradigms that depend on sensory-driven behavior (Dalley et al., 
2004).  In turn, attentional modulation of sensory processing seems to function 
optimally during tasks that demand significant PFC-driven resources (Kastner 
and Pinsk, 2004).  Although there is no evidence that the PFC directly innervates 
brain regions responsible for initial coding of incoming sensory information 
(Kayama, 1985), it is possible that the PFC influences early sensory processing 
indirectly through modulatory circuits activated during generalized arousal or 
engagement in goal-directed behavior.  As such, modulatory systems reciprocally 
connected to the PFC that process and encode information regarding 
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significance of stimuli within a behavioral context must be examined for a role in 
adjusting responsiveness in primary sensory relay networks.      
 
Neuromodulatory systems of sensory processing 
There are multiple brainstem neuromodulatory systems that have been 
implicated in the regulation of  sensory signal processing (Rangel-Gomez and 
Meeter, 2016).  The nucleus basalis of Meynert provides cholinergic input to 
cortical regions of the brain and is acknowledged for its modulatory role in the 
processing of sensory information (Sarter et al., 2001).  The dorsal raphe 
supplies serotonergic input to brain circuits involved in sensory processing and 
behavioral reactions to environmental stimuli (Juckel, 2015).  Dopaminergic input 
from the ventral tegmental area and the substantia nigra has also been shown to 
exert prominent effects on sensory processing (Rangel-Gomez and Meeter, 
2016).  The locus coeruleus is the source of brain wide noradrenergic projections  
and has long been acknowledged for its role in modulating state-dependent 
processing of sensory information (Berridge and Waterhouse, 2003).  Although 
the DA and NE systems are candidates for mediating the effects of MPH on 
sensory processing, their precise role in psychostimulant-induced alterations in 
sensory neuron and sensory circuit responsiveness to afferent inputs is 
unknown.   
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The locus coeruleus – norepinephrine system 
The nucleus locus coeruleus (LC) is the primary source of NE-containing 
fibers to the forebrain and as such LC activation is responsible for NE release 
and initiation of NE modulatory actions in cognitive, sensory, and motor networks 
throughout the forebrain.  The ascending LC-NE system has been implicated in 
regulating behavioral states of arousal and modulating state dependent sensory 
processing, thereby facilitating attention to relevant sensory input (Aston-Jones 
et al., 1999, Berridge and Waterhouse, 2003, Devilbiss et al., 2006).  Thus, 
because MPH blocks reuptake of NE, the LC-NE system is prominent in the 
context of MPH’s potential role in modulating sensory processing.    
LC neurons discharge in two distinct modes, a spontaneously active tonic 
mode and a burst firing phasic mode (Aston-Jones and Cohen, 2005, Berridge 
and Waterhouse, 2003).  Tonic activity corresponds with general levels of 
arousal and follows an increasing gradient through quiet rest, arousal, alert 
attentiveness, and stress.  Phasic bursts of activity occur in response to salient 
stimuli and result in significantly more release of NE in LC terminal fields (Florin-
Lechner et al., 1996).  LC neurons respond selectively in phasic bursts to 
attended target stimuli during performance of a signal detection task (Aston-
Jones et al., 1997, Aston-Jones et al., 1994).  In addition, phasic responsiveness 
has been positively correlated with improved behavioral performance.   
In noradrenergic terminal fields, NE has been shown to potentiate 
stimulus-evoked discharge and enhance ‘signal to noise’ ratios of sensory 
neuron and neural network responses to afferent stimuli throughout the brain 
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(Berridge and Waterhouse, 2003).  NE-induced facilitation of sensory-evoked 
responses throughout the brain occurs in a variety of ways including decreased 
response latencies, increased response magnitudes, and gating of previously 
unresponsive neurons to respond to otherwise subthreshold stimuli during 
conditions of elevated NE concentrations.   For example, Devilbiss and 
Waterhouse (2004) investigated sensory-evoked responses to whisker 
stimulation within the ventroposterior medial thalamus and the barrel field cortex 
of the waking rat during LC activation.  This study demonstrated that tonic 
activation of the LC decreased response latencies of sensory neurons to whisker 
stimulation within the thalamus and cortex according to an inverted-U function.  
They also observed increases in stimulus-evoked excitation and post-excitatory 
inhibition.  In addition, a gating effect was observed such that LC stimulation 
revealed cellular responses to otherwise subthreshold synaptic inputs.  As such, 
it is possible that the LC-NE system plays a regulatory role in modulating the 
excitability of sensory circuits as a means of processing behaviorally relevant 
information according to contextual demands.   
An important reciprocal connection exists between PFC and the LC, one 
that may play a prominent role in modulating sensory signal processing 
according to behavioral context (Arnsten and Goldman-Rakic, 1984, Bouret and 
Sara, 2004, Sesack et al., 1989).  Studies by Jodo et al. (1998) have 
demonstrated that both electrical and chemical stimulation of the PFC exert 
excitatory influences on LC discharge.  It is conceivable that arousal states 
involving goal-directed behavior would activate the PFC, which would in turn 
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increase LC-NE output, thereby fostering in LC projection fields a state of optimal 
preparedness for detecting behaviorally relevant stimuli and ultimately resulting 
in the facilitation of sensory signal transmission in accord with behavioral 
demands.  In other words, top-down modulation of sensory processing may 
significantly require output from the LC-NE system to alter stimulus salience 
through information gathered from a behavioral context.   
MPH blocks neuronal reuptake of NE, thereby enhancing 
neurotransmission within terminal fields of the LC.  MPH has been shown to 
facilitate the processing of incoming stimuli in the somatosensory cortex, 
consistent with previously demonstrated effects of NE in the same terminal field 
region (Drouin et al., 2006, Drouin et al., 2007).  These results indicate that MPH 
is able to facilitate neuronal responses to sensory stimuli, a characteristic feature 
of NE-induced modulation of sensory processing.  As such, it is reasonable to 
predict that blockade of NE reuptake and subsequent elevation of NE 
concentrations in the LC terminal fields can facilitate processing of behaviorally 
relevant sensory information, and thereby improve performance during sensory-
guided goal-driven behavior.    
 
Rodent dorsal lateral geniculate nucleus 
The visual system has long provided a means of investigating influences 
that modulate sensory processing, e.g. behavioral assays that require visually-
guided goal-directed performance (McAlonan et al., 2008, O'Connor et al., 2002, 
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Schneider, 2011, Schneider and Kastner, 2009, Sundberg et al., 2012). For 
example, the sustained attention task requires rats to discriminate and respond 
to presentations of signal and non-signal visual cue events for reinforcement 
rewards (McGaughy and Sarter, 1995). The lateral geniculate nucleus (LGN) of 
the thalamus is the primary sensory relay for visual information from the retina to 
the visual cortex.  Although the dorsal LGN (dLGN) receives input from the 
retina, retinal projections account for less than 10% of its input, meaning that 
over 90% of the afferents to dLGN are derived from modulatory pathways (Van 
Horn et al., 2000).  It was originally thought that top-down modulation of visual 
processing was confined to higher order and more complex cortical regions, 
however, studies conducted during the past decade have provided evidence that 
modulation of visual signals occurs in the visual thalamus of humans and non-
human primates (Kastner et al., 2006, McAlonan et al., 2008, O'Connor et al., 
2002, Schneider, 2011, Schneider and Kastner, 2009).  O’Connor (2002) first 
demonstrated that selective attention during a fixation task enhances LGN neural 
responses to attended stimuli using functional magnetic resonance imaging 
(fMRI), and that attentional modulation was similar to that observed in the visual 
cortex.  McAlonan (2008) then translated these findings to non-human primates 
using single-unit extracellular electrophysiology recordings during participation in 
a selective attention task.  This study found that while remaining fixated on a 
central location, LGN activity was greater when monkeys covertly focused 
attention to a peripheral stimulus within that neuron’s receptive field relative to a 
stimulus outside the receptive field.  Attentional modulation of the LGN was also 
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demonstrated in further human fMRI studies during additional tasks of spatial 
attention and feature-based attention (Schneider, 2011, Schneider and Kastner, 
2009).  Taken together these studies suggest that the LGN may be the first relay 
in the brain where visual signal processing is modulated through top-down 
influences.  
In considering MPH-mediated influences on sensory processing, the 
dorsal portion of the rat LGN (dLGN) is of particular interest because it receives 
substantial input from the LC-NE system (Kayama, 1985, Kromer and Moore, 
1980, Latsari et al., 2004, Papadopoulos and Parnavelas, 1990).  By contrast, 
DA innervation of the dLGN in rats is minimal or non-existent (García-Cabezas et 
al., 2009).  Functional relationships have been demonstrated between the LC 
and dLGN.  Electrical stimulation of the LC or iontophoretic application of NE to 
the dLGN facilitates responses to excitatory input produced by electrical 
stimulation of the optic chiasm (Kayama, 1985, Rogawski and Aghajanian, 
1980a, b) via alpha-1 post-synaptic adrenoreceptors (Rogawski and Aghajanian, 
1982).  Thus, it is likely the MPH-mediated increases of NE in dLGN lead to NE-
like facilitation of visual signal transmission.   
The impact of MPH on dLGN circuit operations may be of additional 
interest in the context of tests of executive functions because of evidence that 
more efficient processing of visual information in the dLGN strengthens 
transmission of information to the visual cortex, thus facilitating higher order 
processing (Alonso et al., 1996, Saalmann and Kastner, 2009, Swadlow and 
Gusev, 2001). Increased responsiveness and synchronous discharge of neurons 
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responding to a given stimulus in the dLGN lead to higher probability of 
effectiveness in eliciting subsequent responses from cortical targets (Alonso et 
al., 1996). This early stage augmentation of visual processing may lead to further 
improvements in performance under normal circumstances and when cognitive 
and physical demands are high. In line with this thinking, the current work 
proposes that MPH-induced enhancement of NE neurotransmission within 
sensory areas such as the dLGN facilitates sensory signal processing and the 
resultant signal augmentation is a key component of the performance enhancing 
effects of psychostimulant drugs. 
 
Goal of the studies  
At present the physiological basis for the performance enhancing effects 
of clinically-relevant doses of MPH is unknown. The goal of the proposed studies 
is to examine the effects of MPH on early stage sensory signal processing in the 
rodent, both in terms of thalamic responsiveness to sensory stimulation and 
rodent performance in a sensory guided signal detection task.  Elucidation of 
psychostimulant-induced effects on sensory signal processing and demonstration 
of sensory enhancement in waking animals provides a much needed link 
between effects on cellular functions and behavioral outcomes.  Each aim 
described in Chapter 2 explores a specific hypothesis related to an overarching 
hypothesis: psychostimulants enhance early stage sensory signal processing 
and behavioral performance in sensory-guided signal detection tasks via 
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enhanced NE neurotransmission in sensory thalamic nuclei.  The proposed 
studies were also designed to provide significant insight regarding the potential 
for psychostimulant drugs to augment early stage sensory signal processing as a 
desirable outcome in otherwise healthy individuals. 
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CHAPTER 2 
HYPOTHESIS AND AIMS 
 
 
Hypothesis   
Enhanced norepinephrine (NE) neurotransmission facilitates neuronal responses 
to afferent stimulation of the dorsal lateral geniculate nucleus (dLGN) in the 
anesthetized rat.  Selective attention to incoming stimuli also enhances LGN 
responsiveness during successful performance of sensory-guided goal-directed 
behavioral tasks.  Therefore, the general hypothesis tested in the current work is 
that psychostimulant agents, such as methylphenidate (MPH), that increase NE 
neurotransmission and improve cognitive performance in assays of attention 
should enhance stimulus-evoked neuronal responsiveness to visual stimuli within 
the rat dLGN and behavioral outcomes during performance of a visual signal 
detection task.  These findings would suggest that NE-mediated augmentation of 
early stage sensory signal processing is a key component of the performance 
enhancing effects of psychostimulant drugs.     
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Specific Aims:   
 
Aim 1   
Determine the effects of increased catecholamine neurotransmission on 
light-evoked single-unit activity within the dLGN of the anesthetized rat.  
Enhanced NE neurotransmission facilitates dLGN responses to afferent 
stimulation and selective attention enhances LGN responsiveness to target 
stimuli.  The hypothesis tested here was that MPH, a pharmacological agent 
capable of enhancing both NE transmission and attention, potentiates dLGN 
neuronal responses to light stimuli.  Using an in vivo multi-channel extracellular 
recording approach, stimulus evoked activity in the dLGN was monitored while 
light flashes were presented to the contralateral eye of the anesthetized rat. 
Baseline responses were compared to those recorded following drug 
administration.  Given that MPH blocks reuptake of both NE and dopamine (DA), 
the catecholaminergic mechanisms underlying the potential enhancement of 
dLGN responsiveness to light stimuli were further explored by evaluating the 
effects of additional compounds with selectivity for blocking reuptake of either NE 
or DA.  Atomoxetine (ATX) was tested because it is a selective inhibitor of NE 
uptake and a non-stimulant drug used clinically in the treatment of ADHD.  
Modafinil and GBR-12909 are selective inhibitors of DA reuptake and were used 
to evaluate DA’s role in modulating sensory signal processing within the dLGN.  
The goal of these experiments was to determine how early stage sensory signal 
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processing is altered by psychostimulant enhancement of catecholaminergic 
neurotransmission.   
 
Aim 2   
Determine the effects of MPH on performance of a visual signal detection 
task.  MPH improves neuronal responsiveness to light stimuli in the anesthetized 
rat; however, the relevance of these findings to behavioral outcomes in the 
waking condition remains uncertain.  The goal of studies in this aim was to 
examine the effects of MPH on performance of a visual signal detection task.  An 
intermediate paradigm, the “observing response and hold task,” was first 
developed to confirm feasibility of evaluating MPH effects on light evoked activity 
within behaving animals.  In this task, animals were required to maintain a nose 
poke position directly below an LED stimulus light to ensure that stimuli were 
received from a fixed orientation.  These studies guided the development and 
execution of experiments using a more complex “modified visual signal detection 
task.”  In this task, subjects were trained to lever press in order to indicate 
whether a brief light stimulus was detected.  Changes in measures of behavioral 
performance, such as accuracy and reaction time were compared before and 
following MPH administration.  The hypothesis examined in this phase of the 
work was that MPH improves measures of behavioral performance in a signal 
detection task.  
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Aim 3   
Determine the effects of MPH on visually-evoked neuronal responses to 
light stimuli within the dLGN of rats performing a visual signal detection 
task.  The next question addressed was the potential for MPH to improve 
neuronal responsiveness to light stimuli used to guide performance of a modified 
visual signal detection task.  The responses of individual neurons and ensembles 
of dLGN neurons to target light stimuli during performance of the modified visual 
signal detection task were evaluated before and following MPH administration.  
The expectation was that MPH-mediated enhancement of catecholamine 
neurotransmission would augment responses to attended stimuli within the dLGN 
and that these effects would parallel enhancements in behavioral performance.   
 
Aim 4   
Determine the effects of MPH on visually-evoked potentials in response to 
light cues within the dLGN of rats performing a visual signal detection task.  
In this phase of the project, the effects of MPH on visual evoked potentials 
(VEPs) recorded during performance of the modified visual signal detection task 
were evaluated.  VEPs are waveforms produced in response to visual stimuli that 
can be extracted from local field potentials within the dLGN.  The expectation 
was that drug-induced changes in VEPs would parallel improved behavioral 
performance and MPH-mediated increases in the speed and strength of signal 
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transmission through the dLGN as determined from analysis of single- and multi-
unit data in anesthetized and waking animals.   
 
Aim 5   
Determine the neurochemical identity of catecholamine inputs to the rat 
dLGN.  MPH enhances electrophysiological indices of early stage sensory 
processing and simultaneously improves rodent performance of a modified visual 
signal detection task.  Given the LC-NE system’s role in modulating state 
dependent sensory processing, it was hypothesized that the facilitating effects of 
MPH on sensory signal processing within the dLGN are mediated through 
enhanced NE transmission.  However, MPH blocks neuronal reuptake of both NE 
and DA.  To further investigate the catecholaminergic mechanisms responsible 
for enhancing dLGN processing of target light stimuli during task performance, 
the rat dLGN was immunostained for tyrosine hydroxylase (TH) and dopamine β-
hydroxylase (DBH), enzymes responsible for synthesis of DA and NE, 
respectively.  Co-localization of TH and DBH within axons confirms the NE 
phenotype and catecholamine-containing fibers.  The hypothesis tested here was 
that catecholaminergic innervation of the dLGN is exclusively noradrenergic. 
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CHAPTER 3 
MATERIALS AND METHODS 
 
Animals 
Male Sprague-Dawley rats (250 – 500 g) (Taconic; Germantown, NY) 
were housed in pairs prior to surgery and individually post-surgery.  Rats were 
allowed to acclimate to the facility, which was temperature and humidity 
controlled, for at least one week following arrival with ad libitum access to food 
and water.  Rats were maintained under a 12/12 h light/dark cycle (lights on at 
7:00 AM), except the cohort of rats used in behavioral experiments which were 
maintained under a reverse light/dark cycle (lights on at 7:00 PM).  All 
experimental procedures were conducted in accordance with the guidelines of 
the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals, and protocols were approved by the Drexel University Institutional 
Animal Care and Use Committee. 
 
Drugs   
MPH, ATX, and GBR-12909 were purchased from Sigma-Aldrich (St. 
Louis, MO).  Modafinil was purchased from Tocris Biosciences (Ellisville, MO). 
Drugs were dissolved in sterile saline in a dosing volume of 1 mg/ml when 
administered via intraperitoneal (i.p.) injection.  For oral administration, the drug 
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solution was either dissolved in sterile saline and infused into a piece of cereal in 
a weigh boat or placed within a dried fruit treat.  Animals were observed until the 
entire treat was consumed.   
 
Surgical implantation of electrodes   
Animals were anesthetized with isoflourane (4% induction, maintained at 1 
– 2% in 95% O2 5% CO2) and positioned in flat skull orientation in a stereotaxic 
frame with atraumatic ear bars.  Body temperature was monitored and 
maintained at 37°C using a rectal probe thermometer and a heating pad.  The 
skull surface was exposed and 4 – 6 jeweler’s screws were fixed to the skull to 
secure electrode implants.  Eight-bundle microelectrodes of formvar-insulated 
nichrome wires (25µm; A-M Systems, Sequim, WA) were fitted into electrically 
grounded 26G guide cannulae and implanted bilaterally in the dLGN of the 
thalamus (AP –4.8, ML ±3.8, DV –4.0) using stereotaxic coordinates (Paxinos 
and Watson, 2007).  Electrode placement was verified using previously 
established anatomical and neurophysiological criteria for dLGN thalamic 
neurons, including activity evoked by light stimulation presented to the 
contralateral eye with a primary response peak latency prior to 65 msec (Marks 
et al., 1988).  Electrode implants were then secured using a connector and dental 
cement.  Animals were allowed to recover for at least one week prior to initiating 
recording experiments.     
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Extracellular recording 
Electrical activity was amplified and discriminated in real time using a 
combination of acquisition, spike discrimination, and analysis software (Sort 
Client and NeuroExplorer; Plexon Inc., Dallas, TX).  Spike channels were 
digitized at 40 kHz and band pass filtered from 250 Hz – 8 kHz and local field 
potentials were digitized at 20 kHz and band pass filtered from 0.7 – 170 kHz 
with 12 bit resolution.  Cumulative raster plots and peri-stimulus time histograms 
(PSTHs) were created from the activity of light-responsive channels recorded 
within the dLGN containing multi-unit ensembles and isolated single-units.  All 
recorded activity was stored for off-line analysis.  Single-unit activity was re-
sorted off-line, according to waveform characteristics and inter-spike interval 
distribution patterns including peak voltage of the waveform, waveform slopes, 
scattergram of the waveform’s first two principal components, spike train auto-
correlogram, and inter-spike interval histogram (Offline Sorter; Plexon; Figure 1).  
The Principal Components Analysis (PCA) represents the features of individual 
waveforms as eigenvectors, thus providing criteria for distinguishing and 
separating action potentials from an ensemble neuronal recording (Chapin and 
Nicolelis, 1999, Devilbiss and Waterhouse, 2002, Richmond and Optican, 1987).  
The magnitude of an eigenvalue for a principal component eigenvector, relative 
to the total of all eigenvalues summed, represents the fraction of the total 
variance between waveforms that has been captured in that PCA dimension.  
The first two principal components usually capture the vast majority of the 
variance.  Generally, the first principal component is largest in those sections of 
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the waveform demonstrating the greatest variance (Offline Sorter; Plexon).  
Following waveform sorting, PSTHs representing single-unit responses were 
constructed for each stimulus intensity and drug condition, then plotted using bin 
widths of 1msec with boxcar smoothing across 3 adjacent bins.  Unit responses 
were examined during vehicle pre-treatment and drug post-treatment conditions.    
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Figure 1.  Representative example of an isolated single unit recorded within 
the dLGN.  A.  Superimposed waveforms of a single unit (average template 
highlighted in yellow) discriminated from the remaining unsorted waveforms (light 
gray) within the selected recording channel.  B.  Cluster view of the waveforms 
as points within a scattergram in two-dimensional principle component space.  
The seperation and lack of overlap in the clusters suggest that the yellow cluster 
represents action potential discharges from a single unit relative to background 
neural activity. 
 
  
A B 
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Analysis of electrophysiological data   
Data were analyzed using custom routines written in MATLAB 
(MathWorks, Inc., Natick, MA).  The parameters of neuronal function that were 
assessed included baseline firing rates and primary light-evoked response 
properties – latency to response onset, latency to maximum response, maximum 
response amplitude, and response area as depicted in Figure 2.  Mean baseline 
firing rates represented as frequency in impulses/sec were calculated over 100 
msec prior to stimulus presentation.  Onset and offset of primary response peaks 
in the PSTHs were determined as the time at which two or more consecutive bins 
crossed a threshold of 3 standard deviations above the average baseline 
discharge.  Onset latencies less than 65 msec were considered to represent 
primary responses to stimuli, and peaks with longer latencies were excluded from 
further analysis.  Maximum peak amplitude and peak response area (the sum of 
all bin values from peak onset to peak offset) were corrected for background 
firing rate by subtracting the mean baseline firing rate from each post-stimulus 
bin.  ‘Gating’ was declared for cells that were initially unresponsive to light stimuli 
of a given intensity but demonstrated prominent responses to the same intensity 
stimulus following drug administration.  All statistical analyses and preparation of 
figures were performed using Prism (GraphPad Software, Inc.) and 
NeuroExplorer software.  
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Operant chambers for behavioral experiments 
Operant chambers (Med Associates, Mt. Albans, VT) were modified with a 
top access opening for animals tethered to electrophysiological equipment.  
Training and testing protocols were controlled and data acquired by MED-PC 
programming software. The chambers were equipped with a house light (2.8W), 
two retractable response levers (left and right), visual (one central LED light and 
two peripheral incandescent lights above each response lever) stimulus modules, 
and a centrally-located nose-poke port on the front wall, with a water delivery 
system on the opposite wall. This orientation requires the rat to face the 
(stimulus) wall and then turn around to face the back (reward) wall to receive 
40l of water reinforcement following a correct behavioral response.  
 
Histological confirmation of electrode placement 
Upon completion of experiments, animals were deeply anesthetized and 
perfused with 4% paraformaldehyde.  Brains were extracted, frozen, sectioned 
and mounted in 30 µm slices through the dLGN, and counterstained with neutral 
red for verification of electrode tracks terminating in the dLGN (Figure 3). 
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Figure 2.  Representative response properties of visually-sensitive cells.  
Raster plot of light-responsive activity and corresponding peri-stimulus time 
histogram of visually-evoked discharge with respect to light stimuli (arrow at time 
= 0 msec) recorded from a single-unit in the rat dLGN.  Raster plots represent 
occurrences of light-evoked responses in temporal relation to stimuli.  Spike rate 
intensities represented as frequency in impulses/second (imp/sec) are plotted in 
bin widths of 1 msec with boxcar smoothing across 3 adjacent bins.  Properties 
of primary light-evoked responses are shown, including latency to response 
onset, latency to maximum peak response, maximum peak amplitude, and peak 
response area.   
 
  
36 
 
 
 
Figure 3.  Histological confirmation of electrode placement.  Representative 
coronal section through the dLGN of the rat thalamus collected from one of the 
subjects upon completion of experimental procedures.  Left: corresponding 
location as depicted in the stereotaxic atlas of the rat brain (Paxinos and Watson, 
2007).  Right: magnification (top = 1.6x, bottom = 5x) of the electrode guide 
cannula and electrode tracts terminating in the dLGN. 
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CHAPTER 4 
 
AIM 1: Determine the effects of enhancing catecholaminergic transmission 
on light-evoked single-unit activity within the dLGN of the anesthetized rat 
 
Rationale  
The dLGN receives substantial input from the LC-NE system (Kromer and 
Moore, 1980, Latsari et al., 2004, Papadopoulos and Parnavelas, 1990).   It was 
demonstrated over three decades ago that electrical stimulation of the LC or 
direct application of NE within the dLGN of anesthetized rat facilitated neuronal 
responses to afferent excitatory stimuli and that the observed enhancements 
were mediated through alpha-1 (α1) post-synaptic adrenoreceptors (Kayama, 
1985, Kromer and Moore, 1980, Rogawski and Aghajanian, 1980a, b, 1982).   
Recent work in monkeys and humans has revealed that selective attention can 
also facilitate early stage visual signal processing in response to target cues 
within the LGN (McAlonan et al., 2008, O'Connor et al., 2002, Schneider and 
Kastner, 2009).  MPH increases extracellular concentrations of the 
catecholamines, NE and DA (Berridge et al., 2006, Bymaster et al., 2002, 
Swanson et al., 2006), and enhances behavioral performance in rodent tasks of 
attention guided by sensory target cues (Berridge et al., 2012, Navarra et al., 
2008, Paterson et al., 2011, Robinson, 2012).  In short, enhanced NE 
neurotransmission facilitates dLGN responses to afferent stimulation and 
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selective attention enhances LGN responsiveness to target stimuli.  Given this 
information, the main hypothesis of AIM 1 is that MPH, a pharmacological agent 
capable of enhancing both NE transmission and attention, will potentiate 
stumulus-evoked neuronal responsiveness to sensory stimuli within the rat 
dLGN.   
To test this hypothesis, we investigated the effects of systemic 
administration of MPH on response properties of individual dLGN neurons in 
anesthetized rats.  Given the LC-NE system’s long established role in the 
modulation of sensory processing (Berridge and Waterhouse, 2003), we 
anticipated enhancement of dLGN neuronal responsiveness to light stimuli as a 
result of MPH-induced blockade of NE reuptake and subsequent increase of NE 
neurotransmission.  However, MPH blocks reuptake of both NE and DA 
(Bymaster et al., 2002, Kuczenski and Segal, 2001, Volkow et al., 2002).  
Although DA innervation of the dLGN is either sparse or non-existent (García-
Cabezas et al., 2009), we further explored the catecholaminergic mechanisms 
underlying the potential enhancement of dLGN responsiveness to light stimuli by 
evaluating the effects of additional compounds with selectivity in blocking either 
NET or DAT.  Atomoxetine (ATX) is a non-stimulant drug used clinically in the 
treatment of ADHD and is a selective inhibitor of NET (Berridge et al., 2006, 
Bymaster et al., 2002).  Modafinil is a wake-promoting agent that has recently 
gained popularity for its cognitive-enhancing properties and is a selective inhibitor 
of DAT, although with low affinity (Battleday and Brem, 2015, Cakic, 2009, 
Chamberlain et al., 2011, Karabacak et al., 2015, Mignot et al., 1994, Repantis et 
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al., 2010, Sahakian and Morein-Zamir, 2015).  Although therapeutic effects 
relative to cognitive or performance enhancement of GBR-12909 have not been 
identified, this compound is selective for blocking DAT with high affinity and was 
also evaluated for its potential to enhance dLGN neuronal responsiveness to light 
stimuli to provide a more comphrehensive investigation of the effects of blocking 
selective catecholamine transporters within the dLGN  (Heikkila and Manzino, 
1984).  We postulated that agents that enhance NE transmission with attention-
enhancing properties would also enhance visually-evoked responses of single 
neurons in the dLGN of anesthetized rats.   
 
Specific materials and methods 
Light stimulation protocol 
For all experimental procedures within the anesthetized preparation, the 
animal was placed in a stereotaxic apparatus with atraumatic ear bars under light 
isoflourane anesthesia (~2% in 95% O2 5% CO2).  A light emitting diode (LED; 
RadioShack© white, clear lens LED light with luminous intensity: 1100 mcd, 
chromaticity coordinates: 660, viewing angle: 100 deg) was positioned centrally 1 
cm in front of and above the head along the midline, and the room was darkened.  
Stimuli of three different intensities (5 msec duration) were delivered in 
pseudorandom order at a rate of 2 stimuli/sec (Hz) using a CED 1401 and a 
script written using Spike2 software (CED, Cambridge, England).  The highest 
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stimulus intensity was a brightness of ~1800 lux, the intermediate stimulus was 
~1200 lux, and the low level stimulus was ~250 lux.   
 
Characterization of light-responsiveness to various intensity stimuli 
One hundred and six light-responsive cells recorded from the dLGN of 
eight animals were characterized for their light responsiveness to the three 
different stimulus intensities prior to any subsequent drug administration or 
analysis.  The distribution of cells responding to light stimuli of different intensities 
was as follows: type I units responded to high intensity stimuli only = 43/106 
cells; type II units responded to both high and intermediate intensity stimuli = 
59/106 cells; and type III units responded to all three – high, intermediate, and 
low intensity stimuli = 4/106 cells (Figure 4).  The effect of decreasing stimulus 
intensity on the properties of light sensitive neurons was evaluated.  Because 
distributions of most PSTH parameters were substantially non-normal, and 
transformations that normalized some group data simultaneously de-normalized 
others, Kruskal-Wallis tests with post-hoc Dunn’s multiple comparison tests were 
used to compare responses among stimulus intensities.  There was an overall 
effect of stimulus intensity on the latency to onset of response (p < 0.0005) with 
post-hoc analysis revealing that latencies increased in response to both 
intermediate and low intensity stimuli as compared to high intensity stimuli  (p < 
0.05; Figure 5a).  Latency to the maximum response was also affected by 
stimulus intensity (p < 0.005) with post-hoc tests revealing that latency increased 
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in response to the low intensity stimulus compared to the high intensity (p < 0.05; 
Figure 5b).   The maximum peak amplitude and the response peak area were 
significantly decreased as stimulus intensity decreased (p < 0.005 and p = 0.005, 
respectively) with post-hoc tests revealing significantly smaller magnitudes of 
response to the intermediate stimulus compared to the high in both conditions (p 
< 0.05; Figure 5c and d, respectively).  Response peak magnitudes in response 
to the low intensity stimulus were not significantly different from responses to 
intermediate or high intensity stimuli. 
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Figure 4.  Three representative types of single-units recorded from the 
dLGN with different thresholds for stimulus intensity.  Top: type I, n = 43/106 
cells that responded to high stimuli only, middle: type II, n = 59/106 cells that 
responded to high and intermediate stimuli, and bottom: type III, n = 4 cells that 
responded to all three stimuli.  Spike rate intensities represented as frequency in 
impulses/second (imp/sec) are plotted in bin widths of 1msec with boxcar 
smoothing across 3 adjacent bins.   
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Figure 5.  Effects of stimulus intensity on properties of light-evoked 
responses in the dLGN.  Mean and SEM of response properties across 
decreasing stimulus intensities.  N = 106 cells responded to the high intensity 
stimulus, a subset of these (n = 59/106 cells) responded to the intermediate 
intensity stimulus, and four cells (n = 4/106) responded to all three stimuli.           
* denotes p < 0.05 between pairs of stimulus intensity.   
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Methylphenidate-induced modulation of light-evoked neuronal responsiveness 
within the dLGN of the anesthetized rat 
Experimental design 
A 2 mg/kg (ip) dose of MPH was chosen in accordance with multiple 
reports of enhancing measures of cognitive function in normal adult rats 
(Navarra, Graf et al. 2008; Jentsch, Aarde et al. 2009; Cain, Wasserman et al. 
2011; Paterson, Ricciardi et al. 2011; Berridge, Shumsky et al. 2012; Robinson 
2012).  These doses are also within the range that produce plasma 
concentrations for exerting therapeutic effects in patients with ADHD and for 
improving cognitive function in healthy adult humans (Sauer et al., 2005, 
Swanson and Volkow, 2002).  Specifically, plasma concentrations following 
administration of clinically efficacious doses of MPH are within the range of 8 – 
40 ng/ml (Swanson and Volkow, 2002) and similar plasma levels are obtained 
after administration of cognitive-enhancing doses in rats (Berridge et al., 2006).  
A 15 minute post-treatment evaluation time over an interval of 15 minutes was 
chosen in accordance with time scales reported to demonstrate significant 
increase of extracellular catecholamine concentrations in the brain (Bymaster et 
al., 2002).  Thus, for each light-responsive cell recorded, PSTHs from unit activity 
were constructed for 15 minute intervals under vehicle pre-drug conditions and 
then again following MPH administration.   
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Methylphenidate-induced effects on properties of dLGN light-evoked neuronal 
responses  
The effects of MPH on responses to light stimuli were tested in n = 63 
cells recorded from eight animals.  Figure 6 illustrates data from a representative 
neuron that demonstrated MPH-induced enhancements, measured by decreases 
in response latencies, increases in response magnitudes, and an example of a 
neuron that was gated into the sensory response pool.  Gating occurs when a 
neuron that is non-responsive to a given stimulus under control conditions 
becomes responsive to that same stimulus under drug-treated conditions.  The 
bivariate scatter plots in Figure 7 show the values for latency and magnitude 
measures for each cell in vehicle pre-treatment condition on the x-axis versus 
drug post-treatment condition on the y-axis for large and intermediate intensity 
stimuli (only four cells responded to low intensity stimuli and these are not 
represented).  Points clustering below the line of identity for latency measures 
indicate cells whose latencies were greater in vehicle compared to drug 
condition, thus signifying a decrease in response latencies or faster responses 
following drug administration.  Additionally, points clustering above the line of 
identity for measures of magnitude indicate cases where cell responses to light 
stimuli increased in magnitude following drug treatment.   
Single-units that responded to a given stimulus in both pre- and post-
treatment epochs were further analyzed with Wilcoxon matched-pairs signed 
rank tests, comparing pre-treatment to post-treatment PSTHs for MPH.  MPH 
administration significantly decreased the latencies of response to high intensity 
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stimuli (median difference in onset latency = -3 msec, p < 0.0001; Figure 7a, 
median difference in peak latency = -1 msec, p < 0.001; Figure 7b).   Following 
MPH treatment, the maximum amplitude of the response was increased (median 
difference = 6.9 impulses/sec, p < 0.0001; Figure 7c) as was the area of the 
response peak (median difference = 40.9 impulses/sec, p < 0.001; Figure 7d).   
MPH also reduced the latencies to response onset (median difference = -
1.5 msec, p < 0.005; Figure 7e) and to the maximum response (median 
difference = -2 msec, p < 0.005; Figure 7f) for intermediate intensity stimuli.  
Correspondingly, the maximum response amplitude (median difference = 5.6 
impulses/sec, p < 0.005; Figure 7g) and the area of the response peak (median 
difference = 22.8 impulses/sec, p < 0.01; Figure 7h) were significantly increased 
for medium intensity stimuli following MPH treatment.  These results indicate that 
dLGN neurons respond more quickly and more robustly to both high and 
intermediate intensity light stimuli after systemic administration of MPH.    
Upon visual inspection, Figure 7 shows that the MPH-induced changes in 
PSTH peaks are not uniformly distributed across the ranges of response 
properties in the sample.  Latencies to response onset or to peak response 
(Figure 4a, b, e, and f) exhibit an overall pattern where the shortest latencies are 
more or less evenly distributed about the line of identity, while the points with the 
longest vehicle pre-treatment latencies fall predominantly below the line, 
indicating that the latencies of the slowest-responding cells are most likely to 
impacted by MPH administration.  In contrast, the peak magnitude measures 
(Figure 7c, d, g, and h) suggest that whereas responses to intermediate intensity 
47 
 
stimuli were almost all increased by MPH, irrespective of initial peak size, the 
responses to high intensity stimuli increased proportionately more if they were 
relatively small under vehicle treatment conditions. Together these observations 
suggest a ceiling effect: peaks that are small and/or slow initially are enhanced 
by MPH, whereas peaks that are initially large and/or fast are less affected. 
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Figure 6.  Representative example of MPH-induced modulation of dLGN 
light-evoked neuronal activity.  PSTHs illustrate the effects MPH treatment on 
responses of a single dLGN neuron to high, intermediate, and low intensity visual 
stimuli.  Histograms are aligned to stimulus onset (time = 0) for each stimulus 
intensity.  Stimuli of three intensities were presented in pseudorandom order at 2 
Hz across pre-treatment control (top) and drug post-treatment (bottom; MPH) 
conditions.  Spike rate intensities represented as frequency in impulses/second 
(imp/sec) are plotted using bin widths of 1 msec with boxcar smoothing across 3 
adjacent bins. Green dashed line: an example of decreased latency to response 
onset following drug post-treatment.  Blue dotted line: an example of decreased 
latency to peak response following drug post-treatment.  An increase in 
frequency can also be observed at the high intensity in the Post-MPH condition 
as compared to the Pre-MPH condition.   Arrow denotes an example of a gated 
response, i.e. one that is not evident under control conditions but becomes 
apparent following MPH administration.   
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Figure 7.  Effects of MPH on properties of visually-evoked responses in the 
dLGN.  Bivariate scatter plots represent vehicle on the x-axis by MPH on the y-
axis values for properties of neuronal activity in response to both high (A – D) 
and intermediate (E – H) stimulus intensities.  Points clustering above the 45 
degree equivalence line indicate that there was increase in the response 
measure following MPH treatment whereas those below the line indicate that 
there was a decrease in the response measure following MPH treatment.  * 
below the line of identity denotes a significant decrease (p < 0.05) in measures 
post-MPH treatment and above the line of identity denotes a significant increase 
(p < 0.05) in measures post-MPH treatment.   
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Methylphenidate-induced effects on gating dLGN responses across stimulus 
intensities  
Neurons were also examined for gating effects following MPH 
administration.  Gating of sensory-evoked discharges in noradrenergic terminal 
fields has been observed previously following LC stimulation or local application 
of NE in both cortical and thalamic sensory circuits (Devilbiss and Waterhouse, 
2004, 2011, Waterhouse et al., 1988).  In these previous experiments, neurons 
initially unresponsive to afferent sensory inputs become responsive during 
periods of elevated noradrenergic neurotransmission.  In the current study, this 
analysis was limited to cells that were initially light-responsive to at least the high 
intensity stimuli.  As a result, the available pool of cells in which gating could be 
observed was limited; n = 60 cells following MPH administration.  After MPH, 15 
of 28 neurons previously unresponsive to the intermediate intensity stimuli 
exhibited a response and 3/57 became responsive to low intensity stimuli.  Thus, 
this analysis showed that following treatment MPH, gating effects were greater in 
response to the intermediate intensity stimulus as compared to the low intensity 
stimulus (p < 0.0001 against the null hypothesis of equal proportions of neurons 
gated from the available pool of neurons for each intensity tested; (Figure 8), 
indicating that pharmacological manipulation is more likely to induce 
responsiveness to an intermediate intensity stimulus than to a small intensity 
stimulus.  In addition to the above sample, cells with no prior response to light 
stimuli at any intensity exhibited responses to high intensity stimuli for three 
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neurons following MPH administration.  Overall, the results indicate that MPH 
can recruit neurons into the sensory response pool. 
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Figure 8.  MPH-induced responsiveness of visually-sensitive dLGN 
neurons.  Illustrated by the bar graphs are the number of cells that discharged in 
response to light stimuli under pre-treatment control conditions (light gray) and 
the number of additional cells where stimulus-evoked discharge became evident 
following MPH treatment; i.e. “gated” responses (dark gray) for each stimulus 
intensity; high, intermediate (Int), and low.  An additional three cells revealed 
light-evoked responses to the high intensity stimulus, an additional 15 cells 
revealed light-evoked responses to the intermediate intensity stimulus, and an 
additional three neurons revealed light-evoked responses to the low intensity 
stimulus following MPH treatment.  * denotes p < 0.0001 against the null 
hypothesis of equal proportions of neurons recruited from available pools of 
neurons between stimulus intensities.   
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Atomoxetine-induced modulation of light-evoked activity within the dLGN of the 
anesthetized rat 
Experimental design 
To evaluate the effect of selective NE reuptake blockade on light-evoked 
activity within the dLGN of the anesthetized rat, a 0.5 mg/kg (ip) dose of 
atomoxetine (ATX) was chosen in accordance with reports of enhancing 
measures of executive function in normal adult rats (Bari et al., 2009, Cain et al., 
2011, Fernando et al., 2012, Jentsch et al., 2009, Paterson et al., 2011, 
Robinson, 2012, Seu et al., 2009)  These doses are comparable to clinically-
relevant concentrations prescribed to adult humans (Sauer et al., 2005).  A 30-
minute post-treatment evaluation time over an interval of 15 minutes was chosen 
in accordance with time scales reported to demonstrate significant increase of 
extracellular catecholamine concentrations in the brain (Bymaster et al., 2002, 
Swanson et al., 2006).  Thus, for each light-responsive cell recorded, PSTHs 
from unit activity were constructed of 15 minute intervals under vehicle pre-drug 
conditions and then again following ATX administration.   
 
Atomoxetine-induced effects on properties of dLGN light-evoked neuronal 
responses  
The effects of ATX on responses to high and intermediate intensity stimuli 
were tested in n = 47 cells recorded from seven animals.  Results were broadly 
comparable to those seen with MPH treatment.  Decreases in response 
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latencies, increases in response magnitudes, and an example of gating can be 
observed in the representative example of ATX-induced modulation of dLGN 
light-evoked neuronal activity in Figure 9.  For high intensity stimuli, the latencies 
to response onset and to peak response were significantly decreased with ATX 
treatment (median difference = -1 msec, p < 0.05 (Figure 10a) and p < 0.05 
(Figure 10b), respectively), and the magnitude measures were significantly 
increased (amplitude; median difference = 7.3 impulses/sec, p < 0.0001; Figure 
5c; area median difference = 60.8 impulses/sec, p < 0.001; Figure 5d).   
In response to the medium intensity stimulus, there was a significant 
decrease in latency to the response onset (median difference = -3.5 msec, p < 
0.0001; Figure 10e) and a trend toward decreased latency to the maximum 
response (median difference = -0.5 msec, p = 0.09; Figure 10f).  Both measures 
of peak magnitude in response to the intermediate stimulus were significantly 
increased following ATX (amplitude median difference = 6.3 impulses/sec, p < 
0.0001, Figure 10g; area median difference = 69.9 impulses/sec, p < 0.0001, 
Figure 10h).  These results indicate that as with MPH, the responses of dLGN 
neurons to light stimuli occur more quickly and more robustly following ATX 
treatment.  In general, ATX facilitated neural responses following the same 
pattern of enhancing modulatory effects.      
The scatterplot patterns in Figure 10 for ATX are not as clear as those of 
Figure 7 for MPH.  Nevertheless, the trends are similar; latency shifts tend to be 
greater for slower responding cells (Figure 5a, b, e, f) and cells with initially 
smaller response amplitudes are increased to a greater extent than those with 
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initially larger magnitude responses (Figure 5c, d, g, and h).  The net effect of 
these changes brought about by ATX is a stronger and faster response of the 
dLGN visual relay circuit to light stimuli.  
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Figure 9.  Representative example of ATX-induced modulation of dLGN 
light-evoked neuronal activity.  PSTHs illustrate the effects of ATX treatment 
on responses of a single dLGN neuron to high, intermediate, and low intensity 
visual stimuli.  Histograms are aligned to stimulus onset (time = 0) for each 
stimulus intensity.  Stimuli of three intensities were presented in pseudorandom 
order at 2 Hz across pre-treatment control (top) and drug post-treatment (bottom; 
ATX) conditions.  Spike rate intensities represented as frequency in 
impulses/second (imp/sec) are plotted using bin widths of 1msec with boxcar 
smoothing across 3 adjacent bins.  Green dashed line: an example of decreased 
latency to response onset following drug post-treatment.  Blue dotted line: an 
example of decreased latency to peak response following drug post-treatment.  
Increases in the maximum peak amplitude and response peak area are apparent 
by visual inspection of frequencies of response peaks (imp/sec) to the 
intermediate stimulus intensity when comparing Post-ATX to Pre-ATX conditions.  
Purple arrow denotes an example of a gated response, i.e. one that is not 
evident under control conditions but becomes apparent following ATX 
administration.   
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Figure 10.  Effects of atomoxetine (ATX) on properties of visually-evoked 
responses in the dLGN.  Bivariate scatter plots represent vehicle on the x-axis 
by ATX on the y-axis values for properties of neuronal activity in response to both 
high and intermediate stimulus intensities.  Points clustering above the 45 degree 
equivalence line indicate that there was increase in the response measure 
following ATX treatment and below indicate that there was a decrease in the 
response measure following ATX treatment.  * below the line of identity denotes 
a significant decrease (p < 0.05) in measures post-ATX treatment and above the 
line of identity denotes a significant increase (p < 0.05) in measures post-ATX 
treatment.   
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Atomoxetine-induced effects of gating responses across stimulus intensities  
Neurons were also examined for gating effects following ATX 
administration.  Similar to the previous MPH experiment, this analysis was limited 
to cells that were initially light-responsive to at least the high intensity stimuli.  As 
a result, the available pool of cells in which gating could be observed was limited 
to 46 cells following ATX administration.  After ATX, 12 of 19 previously 
unresponsive neurons exhibited a response to intermediate intensity stimuli and 
2/45 responded to low intensity stimuli.  Again, gating effects were greater in 
response to the intermediate intensity stimulus as compared to the low intensity 
stimulus (p < 0.0001 against the null hypothesis of equal proportions of neurons 
gated from the available pool of neurons for each intensity tested; Figure 11), 
indicating that pharmacological manipulation is more likely to induce 
responsiveness to an intermediate intensity stimulus than to a small intensity 
stimulus.  In addition to the above sample, we found one neuron with no prior 
response to light stimuli at any intensity exhibited a response to the high intensity 
stimuli following ATX administration.  Overall, the results indicate that ATX can 
recruit neurons into the sensory response pool. 
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Figure 11.  ATX-induced responsiveness of visually-sensitive dLGN 
neurons.  Illustrated by the bar graphs are the number of cells that discharged in 
response to light stimuli under pre-treatment control conditions (light gray) and 
the number of additional cells where stimulus-evoked discharge became evident 
following ATX treatment; i.e. “gated” responses (dark gray) for each stimulus 
intensity; high, intermediate (Int), and low.  One additional cell revealed light-
evoked responses to the high intensity stimulus, an additional 12 cells revealed 
light-evoked responses to the intermediate intensity stimulus, and an additional 
three neurons revealed light-evoked responses to the low intensity stimulus 
following ATX treatment.* denotes p < 0.0001 against the null hypothesis of 
equal proportions of neurons recruited from available pools of neurons between 
stimulus intensities.   
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Modafinil-induced modulation of light-evoked neuronal responsiveness within the 
dLGN of the anesthetized rat 
Experimental design 
Recently, the wake-promoting agent, modafinl (MOD; Provigil ®), has 
gained notoriety as a potential therapeutic agent for ADHD and as a cognitive 
enhancer (Battleday and Brem, 2015, Cakic, 2009, Chamberlain et al., 2011, 
Repantis et al., 2010, Sahakian and Morein-Zamir, 2015), although these 
indications lack FDA approval and studies investigating the drug’s effects on 
cognitive function in rodent behavioral assays have yielded mixed results (Eagle 
et al., 2007, Garcia et al., 2013, Liu et al., 2011, Morgan et al., 2007, Waters et 
al., 2005).  MOD is a weak but highly selective DAT blocker (Karabacak et al., 
2015, Mignot et al., 1994).  We reported that attention enhancing doses of MPH 
and ATX enhance sensory-evoked neuronal activity to light stimuli within the 
dLGN (Navarra et al., 2013).  Since both MPH and ATX share a common 
mechanism in the blockade of NE reuptake, it was suggested that sensory 
enhancement within the dLGN was dependent on blockade of NE reuptake 
transporters and enhanced NE neurotransmission.  To further explore the 
possible dopaminergic component of sensory enhancement within the dLGN, we 
evaluated the putative pro-cognitive drug, MOD (64 mg/kg, ip, 30 minutes post-
administration), for its ability to produce sensory enhancement within the dLGN 
of the anesthetized rat.  The goal of the present study was to compare and 
contrast the effects of MPH, ATX, and MOD on light-evoked discharge of cells in 
the dLGN.  Thus, for each light-responsive cell recorded, PSTHs from unit 
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activity were constructed of 15 minute intervals under vehicle pre-drug conditions 
and then again following MOD administration.   
 
Modafinil-induced effects on properties of dLGN light-evoked neuronal responses  
The effects of MOD on responses to high, intermediate, and low intensity 
stimuli were tested in n = 42 cells recorded from six animals.  A representative 
example of MOD-induced effects on dLGN activity is shown in Figure 12.  The 
bivariate scatter plots in Figure 13 show the values for latency and magnitude 
measures for each cell in vehicle pre-treatment condition on the x-axis versus 
drug post-treatment condition on the y-axis for large and intermediate intensity 
stimuli.   
Single-units that responded to a given stimulus in both pre- and post-
treatment epochs were further analyzed with Wilcoxon matched-pairs signed 
rank tests, comparing pre-treatment to post-treatment PSTHs.  Of 42 cells 
recorded to respond to the high intensity stimuli in both pre- and post-MOD 
treatment conditions, all 42 cells also responded to the intermediate intensity 
stimuli and 17 responded to the lowest intensity stimuli. 
MOD administration significantly decreased the latencies of response to 
high intensity stimuli (median difference in onset latency = 0 msec, p < 0.0005; 
Figure 13a, median difference in peak latency = -1 msec, p < 0.0001; Figure 
13b).   Following MOD treatment, the maximum amplitude of the response was 
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not affected, however the area of the response peak was decreased (median 
difference = -33 impulses/sec, p < 0.05; Figure 13d).   
MOD also reduced the latencies to response onset (median difference = -
1 msec, p < 0.0001; Figure 13e) and to the maximum response (median 
difference = -1 msec, p < 0.005; Figure 13f) for intermediate intensity stimuli.  
Similar to the high intensity condition, the maximum response amplitude was not 
affected while the area of the response peak (median difference = -30.9 
impulses/sec, p < 0.05; Figure 13h) was significantly decreased intermediate 
intensity stimuli following MOD treatment.   
In response to the lowest intensity stimuli, MOD reduced latencies to the 
response onset (median difference = -3, p < 0.0005; Figure 13i) and to the 
maximum response (median difference = -2, p < 0.0001; Figure 13j).  The 
maximum response amplitude was not affected.  Although insignificant, there 
was a trend for MOD to decrease the area of the response peak (median 
difference = -28.26, p = 0.09; Figure 13l) 
These results indicate that dLGN neurons may respond more quickly to 
light stimuli following systemic administration of MOD.  However, MOD was 
unable to enhance response magnitudes and even produced a detrimental effect 
on the areas of the primary response peaks.  While selective blockade of DA 
transport may be sufficient to enhance response latencies to light stimuli within 
the dLGN of the anesthetized rat, it appears that full enhancement of light-
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evoked responsiveness are dependent on enhanced NE neurotransmission 
through blockade of NE reuptake transporters.    
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Figure 12.  Representative example of MOD-induced modulation of dLGN 
light-evoked neuronal activity.  PSTHs illustrate the effects of MOD treatment 
on responses of a single dLGN neuron to high, intermediate, and low intensity 
visual stimuli.  Histograms are aligned to stimulus onset (time = 0) for each 
stimulus intensity.  Stimuli of three intensities were presented in pseudorandom 
order at 2 Hz across pre-treatment control (top) and drug post-treatment (bottom; 
ATX) conditions.  Spike rate intensities represented as frequency in 
impulses/second (imp/sec) are plotted using bin widths of 1msec with boxcar 
smoothing across 3 adjacent bins.  Green dashed line: an example of decreased 
latency to response onset following drug post-treatment.  Blue dotted line: an 
example of decreased latency to peak response following drug post-treatment.   
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Figure 13.  Effects of modafinil on properties of visually-evoked responses 
in the dLGN.  Bivariate scatter plots represent vehicle vs. modafinil values for 
properties of dLGN neuronal activity in response to high, intermediate, and low 
stimulus intensities.  Wilcoxon matched-pairs signed rank tests were conducted 
to compare the activity in pre-treatment and post-treatment conditions.  High: 
There was a significant decrease in latency to response onset (p < 0.005), a 
High Intensity Intermediate Intensity Low Intensity A 
B 
C 
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E
F
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I
J
K
L
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significant decrease in latency to maximum peak response (p < 0.001), and a 
significant decrease in response peak area (p < 0.01) in modafinil conditions as 
compared to vehicle.  Intermediate: There was a significant decrease in latency 
to response onset (p < 0.0001), a significant decrease in latency to maximum 
peak response (p < 0.005), and a significant decrease in response peak area (p 
< 0.05).  Low: There was a significant decrease in latency to response onset (p < 
0.005), a significant decrease in latency to maximum peak response (p < 
0.0001), and a trend towards a decrease in response peak area (p = 0.09).  
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GBR-12909-induced modulation of light-evoked neuronal responsiveness within 
the dLGN of the anesthetized rat 
Experimental design 
Within the anesthetized preparation, we have begun to dissociate the 
effects of differentially blocking specific catecholaminergic reuptake transporters.  
Systemic administration of MPH and ATX, drugs that share a common 
mechanism of blocking NE transport, enhanced both speed and strength of 
dLGN neuronal responses to light stimuli.  MOD, a selective inhibitor of DA 
transport, sped light-evoked neuronal responses, but did not produce any 
enhancement of response magnitudes.  Although MOD is highly selective for DA 
transporters, it binds with very low affinity (Karabacak et al., 2015, Mignot et al., 
1994).  To further understand the consequences of specific transporter blockade 
of either we wanted to evaluate the effects of a more potent selective inhibitor of 
DAT (Heikkila and Manzino, 1984).  We evaluated GBR-12909 (GBR; 30 mg/kg, 
ip, 30 mins post-administration), a dose chosen according to previously reports 
that produced behavioral effects in rodent assays of attention and executive 
function (Fernando et al., 2012, Seu et al., 2009, van Gaalen et al., 2006a, van 
Gaalen et al., 2006b).  Thus, for each light-responsive cell recorded, PSTHs from 
unit activity were constructed of 15 minute intervals under vehicle pre-drug 
conditions and then again following GBR administration.   
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GBR-12909-induced effects on properties of dLGN light-evoked neuronal 
responses  
The effects of GBR on responses to high, intermediate, and low intensity 
stimuli were tested in n = 25 cells recorded from three animals.  The bivariate 
scatter plots in Figure 14 show the values for latency and magnitude measures 
for each cell in vehicle pre-treatment condition on the x-axis versus GBR post-
treatment condition on the y-axis for all stimulus intensities.     
Single-units that responded to a given stimulus in both pre- and post-
treatment epochs were further analyzed with Wilcoxon matched-pairs signed 
rank tests, comparing pre-treatment to post-treatment PSTHs.  Of 25 cells 
recorded to respond to the high intensity stimuli in both pre- and post-GBR 
treatment conditions, all 25 cells also responded to the intermediate intensity 
stimuli and 10 responded to the lowest intensity stimuli. 
GBR administration significantly decreased the latency to response onset 
(median difference = -2 msec, p < 0.05; Figure 14a) and decreased the area of 
the response (median difference = -20.55 impulses/sec, p < 0.01; Figure 14d) to 
high intensity stimuli.  GBR showed a trend to decrease the latency to the 
response onset (median difference = -1, p = 0.06) and a trend to decrease the 
amplitude of the peak response (median difference = -7.893, p = 0.08), while 
significantly reducing the area of the response peak (median difference = -51.39, 
p < 0.05, Figure 14h).   GBR did not produce any significant effects on light-
evoked activity in response to the lowest intensity stimuli.   
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Similar to what we observed with modafinil, the potent and selective DAT 
inhibitor GBR demonstrated some ability to speed components of the dLGN light-
evoked response, but also produced detrimental effects on the magnitudes of the 
response peak.  These results support our previous finding with a selective DAT 
blocker in which DAT blockade alone is insufficient to produce full enhancement 
of light-evoked neuronal responsiveness within the dLGN of anesthetized rats, 
suggesting that enhancement of both speed and strength of response is 
dependent on increased noradrenergic signaling.     
A unique observation emerges when visually inspecting Figure 14.  It 
seems as though GBR affects response latencies differently than the previous 
drugs that we evaluated.  Post-GBR neuronal response latencies assume a 
horizontal-like arrangement across the scatter plot (Figure 14a, b, e, and f).  The 
scatter plots show that the shortest latency neurons become slower and the 
longest latency neurons become faster, almost as if the natural variability within 
dLGN response latencies begins to diminish with GBR treatment.  This 
observation could be meaningful in the context of augmented synchrony within 
the dLGN, where a signal would be sent through the dLGN to higher processing 
areas with a more precise surge of transmission, although not accompanied by 
greater strength of signal transmission.  Because we did not observe this unique 
horizontal-like arrangement of latencies following MOD treatment, it seems that 
this effect is exclusive to GBR treatment and not a property of all DAT selective 
inhibitors.  It would be interesting to further explore whether production of a 
horizontal-like arrangement of response latencies is an exclusive feature of the 
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GBR compound itself or if similar properties would be observed with other high 
affinity DAT selective inhibitors.     
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Figure 14.  Effects of GBR-12909 on properties of visually-evoked 
responses in the dLGN.  Bivariate scatter plots represent vehicle vs. GBR-
12909 values for properties of dLGN neuronal activity in response to high, 
intermediate, and low stimulus intensities.  Wilcoxon matched-pairs signed rank 
tests were conducted to compare the activity in pre-treatment and post-treatment 
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conditions.  High: There was a significant decrease in latency to response onset 
(p < 0.05) and a significant decrease in response peak area (p < 0.01) following 
GBR-12909 treatment compared to vehicle.  Intermediate: There was a trend to 
decrease latency to response onset (p = 0.06), a trend to decrease the response 
peak amplitude (p < 0.08), and a significant decrease in response peak area (p < 
0.05).  Low: GBR-12909 did not produce any significant effects on light-evoked 
activity in response to the low intensity stimuli.  
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Distinguishing the mechanisms underlying differential effects of specific 
catecholamine reuptake blockade 
Experimental design 
After exploring the effects of each catecholamine reuptake blocker on 
single-unit neuronal responsiveness to light stimulation in anesthetized rats, we 
evaluated all drug effects against a vehicle control group in order to provide a 
comprehensive comparison towards distinguishing the mechanisms underlying 
differential effects on light-evoked activity.  Following the same dosing design as 
the previous drug experiments, we administered saline (ip) twice to mimic drug 
pre-treatment and post-treatment intervals (30 mins post-administration) in an 
additional 3 animals (26 units).  PSTHs were constructed of 15 minute intervals 
under both conditions and the response properties for each neuron isolated was 
compared to itself and expressed as a treatment induced percent change [(post-
treatment – pre-treatment)/pre-treatment x 100].  Treatment-induced changes for 
all response properties were calculated for all treatments (saline, MPH, ATX, 
MOD, and GBR) in response to the high intensity stimuli and then compared for 
differences across treatments.   
 
Comparison of drug effects  
Treatment-induced changes in the response properties of single units 
within the dLGN of anesthetized rats to high intensity stimuli were compared 
across treatments.  Kruskall-Wallis tests were conducted to compare percent 
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changes following saline vehicle (VEH; n = 26 units from 3 animals), MPH (n = 
60 units from 8 animals), ATX (n = 46 units from 7 animals), MOD (n = 42 units 
from 6 animals), and GBR (n = 25 units from 3 animals), and then with Dunn’s 
multiple comparisons tests to evaluate differences from vehicle or between 
groups following an overall effect.   
An overall treatment effect was observed in the latency to the response 
onset (H = 17.54, p = 0.0015) with Dunn’s multiple comparisons revealing that 
MPH significantly reduced onset latency as compared to VEH and MOD (p < 
0.05).  There was also an overall effect on the latency to reach the maximum 
peak response (H = 15.63, p < 0.005), where MPH, ATX, and MOD significantly 
reduced the latency as compared to VEH (p < 0.05).  There were main effects of 
treatment on the maximum peak amplitude (H = 57.28, p < 0.0001) and the 
response peak area (H = 57.59, p < 0.0001).  Dunn’s multiple comparisons 
revealed that MPH and ATX increased both measures of magnitude as 
compared to VEH and also as compared to MOD and GBR (p < 0.05).    
When evaluating drug-induced modulation of neuronal responsiveness to 
light stimuli within the dLGN of anesthetized rats, drug effects differed in their 
impacts across response properties by mechanism of action.  MPH, which blocks 
reuptake of NE and DA, produced the most profound effects when compared to 
the percent changes in the VEH control group by significantly decreasing both 
latency to response onset and the maximum peak response while significantly 
increasing response amplitude and area.  The effects of ATX, a selective NE 
reuptake blocker, resembled MPH modulatory actions by decreasing the 
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response peak latency and increasing both measures of magnitude compared to 
VEH controls.  In contrast, MOD and GBR, drugs selective for DA transporter 
blockade, differed from drugs with NE reuptake blocking properties.  Although 
MOD and GBR tended to modestly decrease response latencies compared to the 
VEH controls, DA transporter blockade was not sufficient to enhance properties 
of response magnitudes.  In summary, these data further suggest that full 
enhancement of both speed and strength of signal transmission through the 
dLGN of anesthetized rats is dependent on NET blockade.       
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Figure 15.  Modulatory effects of blocking catecholamine reuptake on dLGN 
responsiveness to light stimuli.  Bar graphs represent percent change values 
for properties of dLGN neuronal activity in response to the high stimulus intensity. 
Kruskal-Wallis tests were conducted to compare percent changes following VEH 
(n = 26 from three animals), MPH (2 mg/kg, i.p., n = 60 units from 8 animals), 
atomoxetine (ATX; 0.5 mg/kg, i.p., n = 46 units from 7 animals), modafinil (MOD; 
64 mg/kg, i.p., n = 42 from 6 animals), or GBR-12909 (GBR; 30 mg/kg, i.p., n = 
25).  Percent change was calculated as [(post-treatment – pre-treatment)/pre-
treatment x 100].  * or # denotes significance (p < 0.05) of post-treatment effect 
between groups or from vehicle, respectively, in Dunn’s multiple comparisons 
test following an overall effect.   
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Table 1.  Drug effects on properties of light-evoked responses within the 
dLGN of anesthetized rats.  Summary of drug effects on light-evoked activity 
within the dLGN of anesthetized rats compared by mechanism of action in 
transporter reuptake blockade.  ↓ arrows indicate a significant decrease as 
compared to vehicle control responses.  ↑ arrows indicate a significant increase 
as compared to vehicle control responses.  
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Discussion 
The results of AIM 1 produced two main conclusions.  1)  MPH and ATX, 
two agents that are used in the treatment of ADHD, are effective in enhancing 
rodent performance in sensory-guided attention tasks, and share a common 
mechanism of action in blocking neuronal reuptake of NE, exert prominent 
facilitating effects on early sensory signal processing in the visual thalamus of the 
anesthetized rat.  These facilitating effects on dLGN neuronal responses to light 
stimuli included decreasing response latencies, increasing response magnitudes, 
and gating neurons into the sensory response pool.  Hence, MPH and ATX 
amplified both the speed and strength of signal transmission in response to 
visual stimuli within the dLGN.  2)  MOD and GBR, agents with ambiguous or no 
indication of efficacy to improve cognitive performance in rodent measures of 
attention and high selectivity for blocking DAT over NET, were able to produce 
some enhancement of response latencies to light stimuli only.   
The first conclusion strongly supports our main hypothesis for AIM 1, i.e. 
pharmacological agents capable of enhancing NE neurotransmission and 
measures of attention in rodents also facilitate stimulus-evoked neuronal 
responsiveness to light stimuli within the rat visual thalamus.  Neurons with 
weaker and/or longer latency responses realized the greatest gains following 
drug administration as observed by Drouin et al. (2007) in the sensory cortex 
following systemic MPH treatment.  In addition, many cells that were previously 
unresponsive to light stimuli exhibited well defined responses to visual inputs 
following MPH or ATX treatment, indicating that both agents were capable of 
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gating responses of dLGN neurons to otherwise sub-threshold stimuli and 
recruiting these cells into the sensory response pool.   As a result of these 
actions, light-evoked responses in the dLGN circuitry had shorter latencies and 
were more robust following drug administration, indicating that attention- and NE-
enhancing drugs can affect early stage sensory processing.  Previous studies 
have provided evidence that more efficient processing of visual information in the 
dLGN strengthens the dynamics of synaptic transmission to the visual cortex, 
thus increasing information transfer to cortical targets and facilitating higher order 
processing of visual signals (Alonso et al., 1996, Saalmann and Kastner, 2009, 
Swadlow and Gusev, 2001).  This early facilitation of visual processing may lead 
to improvements in cognitive performance under conditions where attention to 
visual cues is necessary for favorable behavioral outcomes.      
State-dependent facilitation of signal processing in sensory circuits by the 
LC-NE system is well documented, as reviewed by Berridge and Waterhouse 
(2003).   Likewise, noradrenergic ‘gating’ actions have also been demonstrated in 
both thalamic and cortical regions of the brain (Devilbiss and Waterhouse, 2011, 
Waterhouse et al., 1988).  More specifically, enhancement of dLGN neuronal 
responses to excitatory synaptic inputs by LC stimulation or local iontophoretic 
application of NE has been linked to activation of α1 receptors (Kayama, 1985, 
Kromer and Moore, 1980, Rogawski and Aghajanian, 1980a, b, 1982).  Together 
with these previous results, the present findings suggest that the facilitating 
effects of MPH and ATX on dLGN signal processing are the result of blockade of 
NE transporter function leading to elevated extracellular levels of NE and local α1 
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mediated modulatory influences on stimulus-driven excitation.   Nevertheless, we 
cannot rule out the possibility of additional MPH or ATX effects on circuits that 
are afferent to the dLGN.  A likely target in such a scenario would be the visual 
cortex, which sends feedback to dLGN, directly and indirectly via the thalamic 
reticular nucleus, and is itself a prominent recipient of noradrenergic projections 
from the LC.  Local drug infusion studies could potentially address issues of 
remote versus local effects on dLGN neuronal responses.   
The second conclusion, in which DAT selective inhibitors were able to 
moderately increase the speed of transmission without any improvements in 
signal strength through the dLGN, is partially supportive of our main hypothesis.  
It was proposed that only drugs with the NET blocking mechanism of action 
would enhance light-evoked dLGN neuronal responses, thereby concluding that 
the facilitating effects of both MPH and ATX were noradenergically mediated.  
This idea was derived from the LC-NE system’s established role in the 
modulation of sensory signal processing, the dense innervation of the dLGN by 
the LC, and reports demonstrating either scarce or absent dopaminergic input to 
the dLGN of the rat (Berridge and Waterhouse, 2003, García-Cabezas et al., 
2009, Latsari et al., 2004).  As proposed, this theory is true as MOD and GBR 
either did not improve or produced suppressant effects on the response 
magnitudes.  However, we did observe some improvements in response latency 
with MOD and GBR.  As such, further acknowledgement of possible 
dopaminergic influences on neuronal responsiveness within the dLGN must be 
considered.   
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MOD and GBR may exert their modulation of response latencies through 
DA effects occurring remotely or through weak effects on NE receptor 
mechanisms within the dLGN as compared to those activated by MPH and ATX.  
When considering a common convergence point of catecholaminergic influences 
relative to pharmacological agents effective in improving attention and executive 
function, the medial prefrontal cortex (mPFC) is an obvious source of reference.  
The mPFC receives substantial innervation from both noradrenergic and 
dopaminergic ascending projection nuclei (Chandler et al., 2013, Lammel et al., 
2008).  Although there is no evidence that the mPFC directly innervates the 
dLGN (Kayama, 1985), it is possible that the mPFC indirectly influences early 
sensory processing through a more complex modulatory circuit during conditions 
of pharmacological manipulation.  The mPFC sends significant descending 
projections to the LC (Arnsten and Goldman-Rakic, 1984, Sesack et al., 1989).  
In addition, studies by Jodo et al. (1998) have demonstrated that both pulse and 
chemical stimulation of PFC activity induces an excitatory influence on the LC.  It 
is conceivable that pharmacological agents that increase DA efflux within the 
mPFC, such as MOD and GBR (Carboni et al., 2006, de Saint Hilaire et al., 
2001, Rowley et al., 2014), could activate mPFC circuitry and produce 
downstream effects that mimic a top-down state of arousal (Au-Young et al., 
1999).  For example, mPFC mediated activation of LC could increase 
noradrenergic tone in LC terminal fields, resulting in the facilitation of stimulus-
evoked discharge in the dLGN.   
84 
 
Another explanation for possible interpretation to partially describe MOD 
and GBR’s ability to enhance response latencies within the dLGN could be 
enhanced dopaminergic transmission within the retina.  Although retinal 
projections to the dLGN account for less than 10% of its input (Van Horn et al., 
2000), DA projections to the retina are present in rats and dopaminergic 
influences in the retina could be sufficient to speed the processing of visual 
information prior to reaching the dLGN (Cellerino et al., 1998, Voigt and Wassle, 
1987).  Again, local drug infusion studies could be helpful in determining the 
effects that occur remotely versus locally as well as identifying the contribution of 
other neuromodulatory systems, such as DA, that may influence dLGN neuronal 
responses.  In such a case, DAT blockade may be sufficient to improve response 
latencies.  Nonetheless, the present data demonstrate that full facilitation of 
stimulus-evoked activity within the dLGN of the anesthetized rat is dependent on 
an agent’s ability to block NET, not DAT. 
In summary, the present results demonstrate the potential for cognitive-
enhancing agents, specifically with NET blocking properties, to facilitate early 
stage sensory processing within the dLGN by increasing the speed of 
transmission and magnitude of responses to visual stimuli.  As sensory signal 
processing is an essential component of attention and can affect performance in 
visually-guided tasks, this work is the first to demonstrate the potential for 
sensory enhancement within the dLGN to contribute to the overall performance 
enhancing effects of these agents.   
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CHAPTER 5 
AIM 2:  Determine the effects of methylphenidate on performance of a 
visual signal detection task 
 
Rationale 
Experiments described in Chapter 4 showed that systemically 
administered MPH can enhance transmission of sensory signals through the 
dLGN by reducing the latency and increasing the magnitude of light evoked 
responses, and by gating responses to otherwise sub-threshold visual stimuli in 
the anesthetized rat (Navarra et al., 2013).  Although these data suggest that 
sensory enhancement may be a significant component of the performance 
enhancing effects of psychostimulant drugs, the impact of MPH-mediated 
augmentation of early stage sensory signal processing on behavioral outcomes 
in the waking animal is unknown.  The anesthetized preparation offers 
substantial opportunity to examine and characterize drug actions in the CNS 
under stable, well controlled conditions, but does not account for the dynamics 
and complexity of physiological interactions that exist in the brain under waking 
conditions (Devilbiss and Waterhouse, 2003, Waterhouse, 2003).  Therefore, the 
goal of the current aim was to develop an experimental paradigm that would 
make it possible to evaluate MPH effects on behavior while recording light-
evoked activity within the dLGN during performance of a visual signal detection 
task.  In order to accomplish this goal, a stepwise approach was employed:  1) 
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establish electrophysiological recording techniques within the behaving animal, 
2) implement and optimize a visual signal detection paradigm that could be 
utilized in conjunction with electrophysiological recordings of light-evoked activity 
within the dLGN, and 3) evaluate the effects of MPH on behavioral performance 
of the visually-guided signal detection task.  Based on results obtained in 
anesthetized animals we postulated that MPH would enhance visually-evoked 
responses in the dLGN of waking rats and, in addition, that these effects would 
correspond with improved performance in the signal detection task.   
 
Technical considerations 
Recording dLGN light-evoked activity in the behaving rat 
Receptive fields of dLGN neurons  
A significant challenge that must be considered when attempting to record 
and compare light-evoked responses from the  dLGN of the behaving rat derives 
from the fact that these sensory neurons have intrinsically defined receptive field 
properties (Fukuda et al., 1979).  Consequently, the animal’s position within an 
operant chamber must be controlled to ensure that all stimuli are received from a 
fixed orientation.  After considering several options, we inserted an obligatory 
observing response into the behavioral task, i.e. rats were required to maintain a 
fixed orientation in relation to stimuli within the chamber in order to participate in 
behavioral trials to collect rewards. 
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Preliminary task   
Recording unit activity from behaving animals is challenging for several 
reasons.  Moreover, the ability to successfully record activity from single neurons 
during performance of the proposed visual signal detection task raised additional 
concerns.  First, it is difficult to train rats to maintain stillness for extended 
amounts of time while engaged in motivated goal-directed behavior, and, second, 
rats become agitated and temperamental while tethered to electrophysiological 
equipment as it restricts their freedom of movement and compromises behavioral 
performance.  In recognition of these concerns, initial pilot studies were 
conducted using a simplified version of the visual signal detection task.  In this 
version of the task, rats were required to maintain an observing response, which 
consisted of initiating and holding a nose poke position directly below an LED 
stimulus light, followed by water reward for successfully completing the observing 
response.  This task was identified as the ‘observing response hold task.’  The 
goal of these studies was to demonstrate the feasibility of electrophysiological 
recording before and after drug administration in the dLGN of rats performing 
simple and complex behavioral paradigms.  
 
Observing response hold task 
Observing response training   
Rats were water restricted to 85-90% of their free-feeding body weight to 
provide motivation for operant training and testing.  They were allowed timed 
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access to water every day for at least 10 minutes in addition to days they 
performed in behavioral training or testing, where they were able to obtain water 
within the experiment as reinforcement for correct behavior.   Following one week 
of water restriction and daily handling, behavioral training began.  For a 
sequence of observing response behavioral training stages, see Table 2.  Rats 
were first acclimated to the signal detection operant chambers for up to 1 
hour/day with at least 200 random inter-presentation interval reward deliveries (3, 
5, 7, 10, or 15 seconds) from the water dipper over 3 days.  This acclimation 
period served to eliminate novelty aversion of the chamber and also allowed for 
association of water rewards with the motor sound of the dipper extension into 
the chamber.  Nose poke shaping occurred for up to 3 days and consisted of 
water reward delivery when the rats approached the nose poke aperture or made 
a nose poke response.  Then, observing response hold training progressed over 
three phases where rats learned to maintain nose poke hold positions of 
increasing lengths in order to earn water rewards.  Rats continued to the next 
phase of training after finishing a criterion minimum of 100 successful responses 
over 3 consecutive sessions.  Phase 1 rewarded rats for nose poke holds 
increasing from 50, 250, 500, 750, and 1000 msecs, each increase occurring 
after 10 successful responses and the greatest hold continuing until the end of 
the session, which terminated after a maximum of 100 successful responses or 
30 minutes.  Trials in which the nose poke timer was activated, but not 
maintained for the required duration, would result in resetting of the timer and a 
new trial would need to be initiated.  Phase 2 consisted of increasing holds from 
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500, 625, 750, 1000, and 1500 msecs.  Phase 3 holds were standardized to 
1500 msecs and incorporated random central LED light presentations oriented 
within the visual field directly above the nose poke aperture to ensure that the 
stimulus encompasses the entire visual field.  Once criterion performance on 
Phase 3 of the observing response hold task was achieved, rats were surgically 
implanted with bilateral dLGN electrode bundles and allowed to recover for at 
least one week.  Following recovery from surgery, rats were placed back on 
water restriction, acclimated to tethered experimental conditions for recording of 
electrophysiological data during behavior, and re-trained to criterion performance 
in the observing response hold task (see Figure 16).    
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Table 2.  Behavioral training stages of the observing response hold task.  
Rats were trained to maintain a nose poke position directly below an LED 
stimulus light, followed by water reward for successfully completing the observing 
response.  Nose poke holds progressively increased in length until they reached 
a standard hold of 1500 msec.   
 
  
Chamber/Dipper Acclimation
Nose Poke Shaping - All nose pokes rewarded
Phase 1 Nose poke holds increase from 50, 250, 500, 750, 1000 msec
Phase 2 Nose poke holds increase from 500, 625, 750, 1000, 1500 msec
Phase 3 Nose poke standard hold 1500 msec
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Figure 16.  Observing response hold task.  Left: schematic diagram showing 
the stimulus wall of the signal detection task chamber.  Right: Example of a rat 
with an electrode implant tethered to electrophysiological recording equipment 
initiating a nose poke observing response within the signal detection task 
chamber.  Arrow indicates the position of the LED stimulus light directly above 
the nose poke aperture for illumination of the entire visual field during 
maintenance of an observing response.   
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Observing response hold task test design   
To investigate the potential for MPH to enhance early stage sensory signal 
processing in the observing response hold paradigm, rats were given treats to 
consume that contained MPH (4, 8, 16 mg/kg, po, 30 mins prior to performance 
in the task).  The oral route was chosen over the intraperitoneal route in an 
attempt to increase the translational and clinical significance from these data.  
Doses of MPH were chosen in accordance with multiple reports of these drugs 
enhancing measures of cognitive function during sensory-guided tasks and then 
increased due to potential issues of lower oral bioavailability (Berridge et al., 
2012, Navarra et al., 2008, Paterson et al., 2011, Robinson, 2012).  Test days 
consisted of two runs of the task in which the first run followed a vehicle treat and 
the second run followed a counter-balanced drug dosing design where all rats 
received treats containing all doses of MPH or vehicle.  This design allowed the 
response properties for each neuron isolated to be compared to itself on a given 
day and expressed as a modulation ratio [(post-treatment – pre-treatment)/pre-
treatment x 100].  Drug-induced changes were then compared across each dose 
of MPH.  A minimum of two days was used as a washout period between drug 
doses.    
 
Methylphenidate-induced effects on dLGN light-evoked neuronal responses in 
the behaving rat 
We were able to record and isolate light-responsive single units within the 
dLGN of rats over the duration of performance within and across test sessions, 
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however, the exploratory nature and “technical limitations” (described below) of 
the observing response hold task restricted the collection of sufficient data from 
single units following a dose response of orally administered MPH for quantitative 
analysis.  Therefore, light-responsive multi-unit channel recordings from 
ensembles of neurons within the dLGN were used for further quantification and 
analysis of MPH-induced manipulation of neuronal responsiveness over a 
representative population of units within the dLGN rather than single units.   
 Three of six rats trained to criteria and implanted with bilateral dLGN 
electrodes were included in the statistical analysis following a dose response of 
orally administered MPH (vehicle n = 48 channels, 4 mg/kg n = 30 channels, 8 
mg/kg n = 41 channels, 16 mg/kg n = 43 channels).  The three remaining rats 
were excluded from exploratory testing in the observing response hold paradigm 
because of various technical failures, which are described below, see “technical 
limitations.”  Kruskal-Wallis tests were conducted to compare the percent 
changes of the properties of light-evoked responses between vehicle pre-
treatment and post-treatment conditions, calculated as [(post-treatment – pre-
treatment)/pre-treatment x 100] and Dunn’s multiple comparisons were used to 
investigate specific dose effects following an overall effect. 
The dose response of oral MPH (4 – 16 mg/kg) treatment produced 
overall effects on all measures of the properties of light-evoked responses during 
behavior within the observing response hold task; latency to response onset (H = 
37.10, p < 0.0001; Figure 17A), latency to the maximum peak response (H = 
35.69, P < 0.0001; Figure 17B), maximum peak amplitude (H = 12.82, p = 0.005; 
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Figure 17C), and the response peak area (H = 15.35, p < 0.005; Figure 17D).  
Post hoc tests for Dunn’s multiple comparisons revealed that the 4 mg/kg and 16 
mg/kg doses significantly reduced the response onset latency as compared to 
vehicle treatment (p < 0.05), while all three doses (4, 8, and 16 mg/kg) reduced 
the response peak latency compared to vehicle (p < 0.05).  Correspondingly, the 
higher doses of MPH, 8 mg/kg and 16 mg/kg, both significantly increased the 
magnitudes of the maximum peak amplitude and peak response area compared 
to vehicle treatment (p < 0.05).    
Taken together, oral administration of MPH produces facilitating effects on 
early stage sensory processing within the dLGN by increasing both the speed 
and strength of neuronal responsiveness to light stimuli within the waking rat.  
These results provided very important preliminary data suggesting that MPH-
induced enhancement of sensory signal processing within the dLGN is consistent 
between anesthetized and waking states of the animal.   
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Figure 17.  MPH-induced modulation of dLGN activity during performance 
of an observing response hold task.  Line graphs represent percent change 
values for properties of dLGN multi-unit neuronal activity in response to light 
stimuli. Kruskal-Wallis tests were conducted to compare percent changes 
following a dose response of orally administered MPH (vehicle n = 48 channels, 
4 mg/kg n = 30 channels, 8 mg/kg n = 41 channels, 16 mg/kg n = 43 channels).  
Percent change was calculated as [(post-treatment – pre-treatment)/pre-
treatment x 100].  * denotes significant difference (p < 0.05) from vehicle in 
Dunn’s multiple comparisons test following an overall effect.  
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Technical limitations 
Alternate strategies   
Rats successfully learned to block the nose poke aperture for the specified 
duration, however, they used a variety of positions and combinations of their 
noses and forepaws to fulfill the beam break time requirement.  Some rats also 
learned that the flashing LED light was irrelevant to their reward in this task.  
These rats often disregarded the stimulus and rarely used fixed position with their 
heads oriented to attend towards this irrelevant cue.  This behavior was not 
sufficient to acquire an accurate representation of light-evoked activity over the 
duration of a session or across sessions.  These observations reinforced our 
expectation that the proposed version of the complete visual signal detection task 
would require appropriate orientation towards the light in preparation or 
anticipation of light cues indicating how to respond for successful goal directed 
behavior.   
Motivational challenges  
The task design consisting of two runs of the task was developed for the 
purpose of creating the ability to compare dLGN response properties of light-
evoked activity to itself on a given day and expressed as a modulation ratio.  
Although animals readily performed both runs of the task, this design in 
combination with oral drug delivery revealed a motivational variable related to the 
consumption of drug-containing treats.  As the rats were partially satiated after 
collecting up to 100 water rewards within the first run of the observing response 
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hold task, they became less interested in consuming drug-containing treats prior 
to the second run of the task.  Although not confirmed experimentally, it seemed 
the taste of MPH within the treat was aversive to the rats, especially while they 
were tethered to the electrophysiological recording equipment within the operant 
chambers.  Partial consumption or refusal to consume drug-containing treats 
prior to the second run of the task resulted in multiple incomplete experiments 
and variability in the actual dose of MPH ingested.  Originally, the oral route was 
chosen for behavioral studies in order to increase the translational utility of MPH 
effects in rats as compared to humans.  The oral route was also selected in an 
attempt to limit introduction of aversive factors prior to task performance, such as 
drug injections.  Unfortunately, the oral route presented too much variability in 
drug administration, and all subsequent dosing in the complete visual signal 
detection task was via the intraperitoneal route.    
Single-unit discrimination  
Recording light-evoked activity from well-isolated single neurons in waking 
animals performing a behavioral task is inherently difficult.  Accordingly, the 
majority of data acquired from rats performing the observing response hold task, 
before and after MPH, was in the form of multi-unit recordings.  Multi-unit 
recordings from the dLGN provided a means for assessing the effects of 
pharmacological manipulation on neuronal responsiveness over a representative 
population of cells within the dLGN rather than single units. 
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Conclusions 
The observing response hold task provided important preliminary data that 
informed development and execution of experiments designed to investigate the 
impact of MPH on light-evoked activity within the dLGN of rats performing a 
visual signal detection task.  First, these pilot studies helped refine surgical 
techniques for implantation of chronic electrodes and also further established 
procedures for on-line recording of light-evoked activity within the dLGN of 
behaving rats.   Second, recognition that individual animals adopted alternate 
strategies for maintenance of nose poke holds prompted implementation of the 
complete visual signal detection task in which light cues must be attended for 
successful performance and reward delivery.  Third, the observation of 
incomplete consumption of drug treats and the possibility of unintended dosing 
variability led to the decision to use the intraperitoneal route of drug 
administration. Finally, the data collected from the observing hold response task 
suggest that MPH-induced enhancement of sensory signal processing within the 
rat dLGN is consistent across anesthetized and waking states.  
 
Methylphenidate-induced effects on behavior during a visual signal detection task 
Visual signal detection task 
An operant schedule was used to assess specific components of sensory 
signal processing and detection performance, in a task that was modified from a 
combination of previously reported behavioral paradigms (Brown II et al., 2010, 
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Jentsch et al., 2009, Kimchi and Laubach, 2009, McGaughy and Sarter, 1995), 
see Figure 18.  In the modified signal detection task, rats were trained to initiate 
trials by maintaining an observing response (to ensure that stimuli were received 
from a fixed orientation) for 1500 msec.  Following successful maintenance of the 
observing response, levers were extended and subjects reported whether a brief 
flash of light from the central LED was detected by pressing a lever (e.g. yes – 
left lever, no – right lever) to receive a water reward for a correct choice.  On 
signal trials, a correct response (“hit”) was followed by delivery of a water reward, 
while an incorrect response (“miss”) resulted in a 5 sec timeout.  On non-signal 
trials, a correct response (“correct rejection”) was followed by delivery of a water 
reward, while an incorrect response (“false alarm”) resulted in a timeout. 
Omissions were recorded for any trial in which the full observing response was 
maintained and no lever press response was made. For both signal and non-
signal trials, if a subject failed to maintain a full 1500 msec observing response, 
the levers did not extend, and a new trial had to be initiated. Each session ended 
after 100 successful trials or 30 minutes, which ever came first.  For a complete 
sequence of behavioral training stages, see Table 3.   
All rats were trained to criterion performance on the previously described 
observing response hold task (Phases 1 – 3) prior to further training toward 
criterion on the complete visual signal detection task, where behavioral 
performance was contingent on detection of visual stimuli and indication of 
detection by making appropriate lever responses.  Continued behavioral training 
occurred over four additional phases, following initial lever press shaping.   
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Lever press shaping occurred for up to 3 days.  During lever press 
shaping, no water reinforcement was delivered for nose poke responses to 
encourage exploration of the novel levers extended into the chamber.  Levers 
were extended and peripheral incandescent cue lights above both right and left 
levers were illuminated.  Water rewards were delivered when the rats 
approached, investigated, or pressed either right or left lever.  All rats learned to 
make 100 lever presses in 30 min or less within 3 days.  In phase 4, nose poke 
observation responses were re-introduced and required for initiation of trials.  
Illumination of the nose-poke port indicated that a trial could be initiated. During 
maintenance of the observing response, the central LED would flash on signal 
trials or remain unlit on non-signal trials randomly between trials.  Once a full 
1500 msec observing response was completed, both levers extended along with 
illumination of both peripheral light cues.  Either a left or right lever press 
following the full observing response resulted in water reward delivery.  In phase 
5, following a complete observing response, only the correct lever would extend 
along with illumination of the corresponding cue light, i.e. the left cue light and the 
left lever would extend following a signal trial or the right cue light and the right 
lever would extend following a non-signal trial.  Responses on the correct 
extended lever (forced choice) resulted in reward delivery.  In phase 6, both 
levers extended following a complete observing response, but a cue light was 
only illuminated over the correct response lever (cued choice).  Phase 7 marked 
the final training phase and served to maintain routine baseline performance in 
the complete visual signal detection task following conclusion of training.  In the 
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complete modified visual signal detection task, both levers extended following a 
complete observing response and rats indicated whether or not they detected 
light stimuli without the aid of either peripheral cue light.   
Phases 4 and 5 required subjects to reach a criterion of 100 successful 
responses before the end of a 30 min session, on three consecutive days before 
graduating to the next phase.  Phases 6 and 7 required rats to achieve greater 
than 80% correct responses over 3 consecutive test sessions with less than 20% 
omissions (trials in which an observing response was completed, but no lever 
response was made within a 5 second limited hold period).     
Once criterion performance was achieved in the full visual signal detection 
task, rats were implanted bilaterally in the dLGN with extracellular recording 
electrode bundles and then allowed to recover for at least one week. Following 
recovery from surgery, rats were acclimated to tethered experimental conditions 
for recording of electrophysiological data during behavior and re-trained to pre-
surgery baseline performance in the visual signal detection task. 
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Table 3.  Behavioral training stages of the modified visual signal detection 
task.  Rats first completed all stages of the observing response hold task prior to 
training on the modified visual signal detection task.  Following a successful 
observing response, rats learned to indicate by lever press whether or not they 
detected a stimulus light.  In Phase 4, any lever press following a successful 
observing response was rewarded.  In Phase 5, only the correct lever was 
presented and forced choice lever presses were rewarded.  In Phase 6, both 
levers were presented, but a cue light (separate from the LED stimulus light, see 
Figure 16) was presented over the correct lever and the cued choice lever 
presses were rewarded.  In Phase 7, both levers were presented, and rats 
indicated whether or not they detected the stimulus light.  Phase 7 was the final 
training phase and used for maintaining routine baseline performance.   
Chamber/Dipper Acclimation
Nose Poke Shaping - All nose pokes rewarded
Phase 1 Nose poke holds increase from 50, 250, 500, 750, 1000 msec
Phase 2 Nose poke holds increase from 500, 625, 750, 1000, 1500 msec
Phase 3 Nose poke standard hold 1500 msec
Lever Press Shaping - All lever presses rewarded
Phase 4 Reward any lever press following successful observing response
Phase 5 Reward forced choice on correct lever
Phase 6 Reward cued choice on correct lever
Phase 7 Reward signal detection indication on correct lever
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Figure 18.  Modified visual signal detection task.  Rats were trained to initiate 
trials by maintaining an observing response (to ensure that stimuli are received 
from a fixed orientation) for 1500 msec.  Following successful maintenance of the 
observing response, levers were extended and subjects reported whether a brief 
flash of light from the central LED was detected by pressing a lever (e.g. yes – 
left lever, no – right lever) to receive a water reward for a correct choice.  On 
signal trials, a correct response (“hit”) was followed by delivery of a water reward, 
while an incorrect response (“miss”) resulted in a 5 sec timeout.  On non-signal 
trials, a correct response (“correct rejection”) was followed by delivery of a water 
reward, while an incorrect response (“false alarm”) resulted in a timeout. 
Omissions will were recorded for any trial in which the full observing response 
was maintained and no lever press response was made. On both signal and non-
signal trials, if a subject failed to maintain a full 1500 msec observing response, 
the levers did not extend, and a new trial had to be initiated. Each session ended 
following either 100 successful trials or 30 minutes.  
104 
 
Visual signal detection task test design 
To investigate the potential for MPH to enhance early stage sensory signal 
processing in our modified visual signal detection task, MPH (0.5 and 2 mg/kg, 
ip,) was administered 15 mins prior to performance.  Doses of MPH were chosen 
in accordance with multiple reports of this drug enhancing measures of cognitive 
function during sensory-guided tasks (Berridge et al., 2012, Navarra et al., 2008, 
Paterson et al., 2011, Robinson, 2012) and producing plasma levels in rats 
similar to clinically prescribed doses in humans (Berridge et al., 2006, Swanson 
and Volkow, 2002).  Test days consisted of two runs of the task in which the first 
run followed vehicle administration and the second run followed a counter-
balanced drug dosing design where all rats received all doses of MPH or vehicle.  
A minimum of two days was used as a washout period between drug doses.  
This test day design allowed behavioral measures and light-evoked response 
properties of dLGN neurons to be compared to their own baseline values on a 
given day and then be expressed as a modulation ratio [(post-treatment – pre-
treatment)/pre-treatment x 100], or percent change.  Drug-induced changes were 
then compared across each dose of MPH.   
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Methylphenidate effects on behavioral performance of the visual signal detection 
task  
Accuracy    
Percent accuracy [hits + correct rejections / all response outcomes within 
a session (i.e. hits + correct rejections + misses + false alarms)] was calculated 
for both test day runs. Run-to-run change in performance accuracy, or percent 
change, was used to compare behavioral accuracy for each drug and dose.  
Repeated measures ANOVA and planned contrasts with Bonferroni corrections 
(each dose of MPH in comparison to saline control, corrected alpha = 0.025) 
were conducted to investigate the effect of MPH performance accuracy.   
MPH did not affect accuracy in rats highly trained in the modified visual 
signal detection task as evaluated by the repeated measures ANOVA (F (1.848, 
9.240) – 1.129, p = 0.3593) or paired t-test comparisons (p > 0.05 both doses of 
MPH, 0.5 and 2 mg/kg) as shown in Figure 19A.  It is worth noting that rats 
generally performed the modified version of the visual signal detection task with 
greater than 90% accuracy and it is likely that their performance accuracy had 
already reached a ceiling that did not allow for a sufficient therapeutic window to 
observe possible facilitating effects on this measure.   
Reaction time   
Due to the fact that performance levels were consistently high in these 
well trained animals, analysis of latencies was restricted to correct trials (hits and 
correct rejections); sample sizes of incorrect trials were negligible and hindered 
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reliable computation.  Latencies of correct trials were trimmed of three longest 
and shortest values.  The longest latencies up to 5 secs were considered to 
reflect alternate behaviors (random lever pressing) and treated as nuisance 
variables.  By standard statistical practice, the removal of the three highest 
values dictated that we removed the three lowest values.  Modulation ratios for 
hits and correct rejections were calculated as percent change of trimmed mean 
latencies.  Percent change in hits, correct rejections, and the combined correct 
response reaction time (computed as the mean of hit and correct rejection 
average change) were compared across treatment levels.  We conducted 
repeated measures ANOVA and planned contrasts using Bonferroni corrections 
(each dose of MPH in comparison to saline control, corrected alpha = 0.025) to 
investigate the effect of MPH on measures of reaction time latency.   
Repeated measures ANOVA did not reveal overall effects of MPH on 
reaction times for hits, correct rejections, or combined correct responses [F 
(1.922, 9.610) = 1.615, p > 0.05, 0.2482; F (1.380, 6.902) = 1.554, p > 0.05, 
0.2663; and F (1.283, 6.414) 1.917, p > 0.05, respectively].  Paired t-tests with 
Bonferroni corrections did not reveal significant effects of MPH on latencies to 
make hits or correct rejections alone at either dose of MPH, but did reveal that 
MPH (2 mg/kg) had significantly decreased the percent change in latency of the 
combined correct responses compared to saline control (p = 0.0118; Figure 19B).  
Speeding reaction times to make correct responses within the modified signal 
detection task suggests that although MPH did not improve response accuracy in 
high performing rats, rats did perform the modified visual signal detection task 
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with greater efficiency following the 2 mg/kg dose of MPH.  These data 
correspond well with reports demonstrating MPH improves reaction times during 
performance of signal detection tasks in rats and humans with and without ADHD 
(Bizarro et al., 2004, Coghill et al., 2014, Eagle et al., 2007, Nandam et al., 2011, 
Navarra et al., 2008, Spencer et al., 2009).  
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Figure 19.  Effects of MPH on behavior during performance of the modified 
visual signal detection task.  Percent change values for measures of signal 
detection task behavior (n = 6 rats).  Percent change was calculated as [(post-
treatment – pre-treatment)/pre-treatment x 100].  Accuracy = proportion of correct 
responses.  Correct response reaction time = mean latency from lever extension 
to correct response (hits and correct rejections combined).  * denotes p < 0.025 
from saline in a planned comparison with Bonferroni correction.    
A B 
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Reaction time variability   
In addition to reports that MPH improves reaction time in signal detection 
tasks (Bizarro et al., 2004, Eagle et al., 2007, Navarra et al., 2008), reductions in 
reaction time variability are often observed following MPH treatment in humans 
with ADHD (Coghill et al., 2014, Kofler et al., 2013, Nandam et al., 2011, Ni et al., 
2016, Spencer et al., 2009), and in some cases observed independently without 
accompanying improvements in reaction time itself (Bron et al., 2014, Epstein et 
al., 2011).  Reducing reaction time variability to make lever press responses 
indicating whether or not a signal has been detected would suggest that the goal-
directed behavior is being performed in a more controlled and temporally precise 
manner within a given physiological condition.  As such, we calculated the 
percent change in reaction time variability (the standard deviation of reaction 
times within each run of the task) for each type of correct response latency, i.e. 
hits, correct rejections, and the mean of both types of correct responses within 
each treatment condition.  One-way ANOVAs were conducted to compare the 
percent change in reaction time variability between the first run in the saline 
control condition and the second run treatment condition.  There were no 
statistically significant differences between group means when evaluating hit 
latencies (F (2,1 5) = 0.2372, p = 0.7917; Figure 20A), correct rejection latencies 
(F (2, 15) = 1.664, p = 0.2225; Figure 20B), or the averaged correct response 
latencies (F (2, 15) = 0.3654, p = 0.6999; Figure 20C).   
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Figure 20. Percent change in reaction time variability to make correct 
responses.  Bar graphs represent percent change values of the variability, 
measured as standard deviation, in reaction times to make correct lever 
responses. Percent change was calculated as [(post-treatment – pre-
treatment)/pre-treatment x 100].  
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Discussion 
In this phase of the project our primary aim was to develop an 
experimental paradigm that could be used to evaluate MPH effects on behavior 
and light-evoked activity within the dLGN of rats performing a visual signal 
detection task.  This goal was achieved in three steps.  First, we established 
electrophysiological recording techniques in the dLGN of waking rats by utilizing 
a simplified observing response paradigm.  Second, we developed and optimized 
a modified visual signal detection task that allowed for recording stimulus-evoked 
neuronal activity within the dLGN of behaving rats.  Third, we evaluated the 
effects of MPH on behavioral performance within the modified visual signal 
detection task. 
The results of these studies yielded two main conclusions and provided 
valuable insight into potential pitfalls and solutions associated with 
electrophysiological recording in behaving animals.   First, MPH-induced 
enhancement of light-evoked dLGN activity is consistent across anesthetized and 
waking states using the observing response paradigm.  For example, as seen in 
the anesthetized preparation MPH reduced dLGN latencies to the onset and 
maximum peak responses.  MPH also dose-dependently increased response 
magnitudes, including the maximum peak amplitude and the response peak 
area.  Second, MPH improved behavioral performance of a modified visual signal 
detection task by decreasing latencies to make correct responses.  These results 
correspond well with multiple reports demonstrating improved reaction times on 
signal detection tasks in both rats and humans following MPH administration 
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(Bizarro et al., 2004, Coghill et al., 2014, Eagle et al., 2007, Nandam et al., 2011, 
Navarra et al., 2008, Spencer et al., 2009).  Moreover, the outcomes of these 
experiments support the hypothesis stated in Aim 2, i.e. MPH-mediated 
enhancement of visually-evoked neuronal responses in the dLGN of waking rats 
and these effects parallel improved performance in a visually-guided signal 
detection task.  
 
Behavioral outcomes  
 Although preliminary in nature, the demonstration of MPH-induced 
enhancement of light-evoked dLGN neuronal activity within rats performing the 
observing response hold task was a significant step forward; one that confirmed 
feasibility of the overall experimental approach and informed development of the 
modified visual signal detection task.  Importantly, this was the first time drug-
induced modulation of early stage sensory processing was observed within the 
dLGN of waking rats.  These experiments begin to bridge our understanding of 
MPH effects across anesthetized and waking conditions.   
One of the unique aspects of the study was the ability to control the 
orientation of the animal with respect to presentation of the stimulus within the 
visual field.  Information is delivered to the dLGN according to a retinotopic map.  
Prior studies were conducted in anesthetized animals with good control over 
receptive field orientations.  However, behavioral studies in waking animals 
demand consideration of the receptive fields of recorded cells.  This experiment 
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addressed this concern by requiring the rats to maintain a nose poke position 
within the operant chamber to ensure that all stimuli were received from a fixed 
orientation that would illuminate the entire visual field.  Light-evoked neuronal 
responses could then be measured over the duration of a test session and then 
compared across experimental test sessions.    
The simplified observing response paradigm exposed a number of 
methodological considerations, both electrophysiological and behavioral, that 
needed to be addressed prior to moving forward with development of the full 
modified visual signal detection task.  In terms of the electrophysiological 
method, techniques for surgical implantation of electrode bundles and long-term 
recording from individual cells and ensembles of neurons in the dLGN were 
refined.  The preliminary behavioral studies revealed variations in behavioral 
strategies and motivational factors across subjects that were accounted for in the 
final modified visual signal detection task. 
The most significant difference in moving from the preliminary observing 
response hold task to the full modified visual signal detection task was that the 
light stimulus used to measure dLGN neuronal responsiveness would change in 
terms of its behavioral relevance.  In the observing response task, light stimuli 
were irrelevant to task performance.  In the modified visual signal detection task, 
the light stimuli were behaviorally relevant and successful goal-directed 
performance within the task was contingent on indication of whether or not the 
stimulus light was detected.  In this regard, light stimuli acquired a valence within 
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the task and rats readily attended the LED stimulus location while maintaining 
nose poke observing responses 
MPH was investigated for its potential to affect behavioral performance in 
the modified visual signal detection task.  This task was straight forward in design 
as the primary goal was to investigate MPH-induced augmentation of sensory 
processing within the dLGN using behavior as an outcomes measure.  We 
observed that MPH did not affect behavioral accuracy in rats highly trained in this 
task.  However, this experimental design may not be complex enough to reveal 
drug-induced improvements in performance accuracy due to “ceiling effects” in 
the behavior.  Rats were highly trained in the modified visual signal detection 
task; routinely achieving 90-100% accuracy prior to drug testing.  In order to 
offset “ceiling effects,” task difficulty could be increased by adding auditory 
distractors or lowering the contrast of target stimuli during behavior, thus 
disrupting performance and creating a window in which drug-induced 
improvements in performance could be further investigated.  In pilot studies, we 
have in fact observed differences in task accuracy and dLGN unit responding 
with different stimulus light durations (Figure 21). 
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Figure 21.  Representative example of multi-unit neuronal activity in 
response to short and long stimulus durations.  PSTHs illustrate the effects 
of stimulus duration on light-evoked activity within the dLGN of a rat performing a 
pilot version of the visual signal detection task.  Histograms are aligned to 
stimulus onset (time = 0) for each stimulus duration; 1msec (left) and 5msec 
(right).  Stimuli of 1 msec or 5msec were presented in pseudorandom order 
throughout the experimental test session.  Spike rate intensities represented as 
frequency in impulses/second (imp/sec) are plotted using bin widths of 1 msec 
with boxcar smoothing across 3 adjacent bins. Longer light stimuli elicited neural 
responses of shorter latency and higher magnitude and corresponding behavior 
responses of greater accuracy.    
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Although we did not observe MPH-induced improvements in performance 
accuracy, we have demonstrated that MPH reduced the latency to make correct 
responses in the modified visual signal detection task as compared to vehicle 
control treatment.  These findings suggest that while the percentage of correct 
responses did not change, correct responses were made with greater efficiency 
during performance of the task.  Quantification of reaction time latencies shows 
there is a general increase in reaction time in the second run of the task as 
compared to the first following saline administration, while administration of MPH 
(2 mg/kg) reverses this effect (Figure 19).  This increased latency effect may 
result from the testing paradigm which requires animals to perform two runs of 
the task for the purpose of comparing electrophysiological and behavioral 
measures from each animal to their own baseline for each testing day.  
According to this protocol, animals may collect up to 100 water rewards for 
optimal performance prior to the second run.  Although this feature of the 
paradigm may consequentially decrease the motivational and arousal state of the 
animals during the second run of the task, it is apparent from the data that MPH 
administration not only diminishes these effects, but in addition produces a 
decrease in reaction time in the second run of the task as compared to the first. 
Improvement in reaction time during performance of signal detection tasks 
is a characteristic feature of MPH action across studies in both rodents and 
humans (Bizarro et al., 2004, Coghill et al., 2014, Eagle et al., 2007, Nandam et 
al., 2011, Navarra et al., 2008, Spencer et al., 2009).  Given this information, we 
also investigated MPH’s potential to affect reaction time variability and whether 
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MPH produced differential effects on correct responses depending on the type of 
correct response, i.e. hit or correct rejections, but we did not find any significant 
or biologically relevant differences in those analyses.   
 
Electrophysiological findings 
During these experiments, light-evoked activity was recorded from the 
dLGN while rats performed the modified visual signal detection task.  We 
demonstrated that MPH enhances light-evoked neuronal responses within the 
dLGN of the waking rat in a simple observing response task.  We also showed 
that MPH improves behavioral outcomes by decreasing reaction times to make 
correct responses, thus increasing the efficiency with which rats performed the 
modified visual signal detection task.  Additional studies described in Chapter 6 
investigated the effects of MPH on single-unit and multi-unit activity in response 
to light stimuli during performance of the modified visual signal detection task.  
Chapter 7 describes experiments designed to characterize the effects of MPH on 
visual evoked potentials in response to light stimuli during performance of the 
modified visual signal detection task.  Together this work demonstrates for the 
first time MPH-induced enhancement of electrophysiological indices of early 
stage sensory processing in rats during performance of a visual signal detection 
task.    
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CHAPTER 6 
 
AIM 3:  Determine the effects of methylphenidate on visually-evoked 
neuronal activity in response to light stimuli within the dLGN of rats 
performing a visual signal detection task 
 
Rationale 
In the previous chapter, an experimental platform was developed that 
made possible the evaluation of MPH effects on behavior while recording light-
evoked activity within the dLGN of rats performing a visual signal detection task.  
During this process, we showed that MPH produced enhancing effects on dLGN 
light-responsive activity similar to that observed in the anesthetized state within a 
subset of rats performing an intermediate observing response and hold task.  
These results indicate that rats can successfully maintain an observing response, 
i.e. hold a fixed posture for 1.5 secs while positioned in the nose poke aperture.  
Furthermore, although the stimulus lights were irrelevant for successful 
performance of the observing response hold task, we demonstrated that we 
could record light-evoked activity within the dLGN of behaving animals.  
Importantly, the quality of these recordings was sufficient to compare light-
evoked activity between experimental sessions before and after drug 
administration.  These data, although preliminary in nature, provided great insight 
towards the successful development of the ultimate version of our proposed 
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modified visual signal detection task.  Finally, we demonstrated that MPH can 
enhance behavioral performance by reducing reaction times of rats to make 
correct responses in our modified visual signal detection task.   
The goal of experiments in Aim 3 was to evaluate the effects of MPH on 
electrophysiological correlates of dLGN unit discharge in response to stimulus 
lights during performance of the modified visual signal detection task.  We 
recorded neuronal activity from the dLGN of behaving animals before and after 
administration MPH using multi-channel, multi-neuron recording approaches.  
We postulated that MPH would enhance cue light evoked neuronal discharges 
within the dLGN and that these effects would positively correlate with improved 
performance in the signal detection task.   
 
The effects of MPH on light-evoked activity within the dLGN of rats performing a 
visual signal detection task 
MPH effects on multi-unit activity 
The effects of MPH (0.5 and 2 mg/kg, ip) on dLGN multi-unit neuronal 
responses to light stimuli were evaluated first (vehicle n = 60 channels, 0.5 mg/kg 
n = 69 channels, 2 mg/kg n = 71 channels).  Drug was administered 15 min prior 
to task performance and collection of electrophysiological data.  Kruskal-Wallis 
tests were conducted to compare percent changes for properties of light-evoked 
responses across doses and Dunn’s multiple comparisons were investigated 
following determination of an overall effect.  
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MPH administration significantly affected light-evoked ensemble activity.  
A representative example of MPH’s facilitating effects on light evoked multi-unit 
discharge following the 2 mg/kg dose is shown in Figure 22.  MPH produced an 
overall effect on the latency to the response onset (H = 12.94, p = 0.0015; Figure 
23A) and Dunn’s multiple comparisons test revealed that the 2 mg/kg dose 
significantly reduced onset latency compared to vehicle control (p < 0.05).   An 
overall effect on the latency to reach the maximum peak response was also 
significant (H = 19.12, p < 0.0001; Figure 23B) with the 2 mg/kg dose decreasing 
the latency compared to control (p < 0.05).  MPH produced a dose-dependent 
increase in the maximum peak amplitude (H = 12.97, p = 0.0015; Figure 23C) 
with both doses increasing the amplitude as compared to control (p < 0.05), 
without significantly affecting total area of the primary response (H = 4.910, p = 
0.0859; Figure 23D).   
MPH’s facilitating effects on dLGN multi-unit activity included decreasing 
latencies to the onset and to the maximum peak of the response, while 
increasing the maximum peak amplitude.  We did not observe a significant 
augmentation of the total response peak area accompanying the increase in 
peak amplitude.  However, it is worth noting post-drug changes in the profile of 
light evoked responses that account for minimal or no changes in total response 
peak area.  The PSTH records in Figure 22 are representative of frequently 
observed changes in dLGN multi-unit response profiles following drug 
administration.  In this case the light evoked excitation is increased and a post-
excitatory inhibition that was not previously evident under saline conditions 
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becomes prominent.  Together these changes are reminiscent of norepinephrine-
mediated changes in excitatory and inhibitory components of rat visual cortical 
neuron responses to moving bars of light; modulatory effects that serve to 
sharpen the receptive field borders of these sensory cells (Waterhouse et al, 
1990).  As such, a legitimate comparison of total response peak areas under 
saline versus drug conditions is no longer possible because of the changes in 
response profile.   
In summary, the MPH-induced changes in dLGN multi-unit responses to 
light stimuli presented during performance of the modified visual signal detection 
task were consistent with those observed in the anesthetized rat.    
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Figure 22.  Representative example of MPH effects on multi-unit activity 
during performance of the modified visual signal detection task.  PSTHs 
illustrate the effects MPH treatment on responses of a multi-unit light-responsive 
channel within the dLGN.  Histograms are aligned to stimulus onset (time = 0) 
during pre-treatment control (top; saline) and drug post-treatment (bottom; MPH 
2 mg/kg) conditions.  Spike rate intensities represented as frequency in 
impulses/second (imp/sec) are plotted using bin widths of 1 msec with boxcar 
smoothing across 3 adjacent bins. Green dashed line: an example of decreased 
latency to response onset following drug post-treatment.  Blue dotted line: an 
example of decreased latency to peak response following drug post-treatment.  
An increase in the maximum peak amplitude is apparent across the pre- and 
post-MPH PSTHs.   
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Figure 23.  MPH effects on multi-unit activity during performance of the 
modified visual signal detection task.  Line graphs represent percent change 
values for properties of dLGN single-unit neuronal activity in response to light 
stimuli following a dose response MPH (vehicle n = 60 channels, 0.5 mg/kg n = 
69 channels, 2 mg/kg n = 71 channels).  A and B.  Latency to response onset 
and maximum peak response measured in milliseconds (ms), respectively.  C 
and D.  Maximum peak amplitude and response peak area measured in 
impulses/second (imp/s).  * denotes significant differences (p < 0.05) from vehicle 
in Dunn’s multiple comparisons following an overall effect in Kruskal-Wallis tests. 
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MPH effects on single-unit activity 
The effects of MPH (0.5 and 2 mg/kg, ip) on dLGN single-unit responses 
to light stimuli presented during the modified visual signal detection task were 
also evaluated (vehicle n = 28 cells, 0.5 mg/kg n = 25 cells, 2 mg/kg n = 31 cells).  
Drug was administered 15 mins prior to task performance and collection of 
electrophysiological data.  To compare pre-treatment to post-treatment PSTHs 
for each treatment epoch within a given test day, single-units were analyzed with 
Wilcoxon matched-pairs signed rank tests.   To compare percent changes for 
properties of light-evoked responses across treatment test days, Kruskal-Wallis 
tests were conducted and Dunn’s multiple comparisons were investigated 
following determination of an overall effect.  A typical single unit displaying MPH-
induced facilitation of latency and magnitude of light-evoked responses to light 
stimuli within the visual signal detection task is shown in Figure 24. 
Modulation within treatment days   
Latency and magnitude measures for each cell are shown in the bivariate 
scatter plots in Figure 25.  Vehicle pre-treatment condition was plotted on the x-
axis versus drug post-treatment condition on the y-axis for saline, MPH 0.5 
mg/kg, and MPH 2 mg/kg.  Points clustering below the line of identity for latency 
measures indicate cells whose latencies were greater in vehicle compared to 
drug condition, thus signifying a decrease in response latencies or faster onset of 
evoked discharges following drug administration.  Additionally, points clustering 
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above the line of identity for measures of magnitude indicate cases where cell 
responses to light stimuli increased in magnitude following drug treatment.   
Post-treatment with either saline (Figure 25A – D) or MPH (0.5 mg/kg, ip; 
Figure 25E – H) did not produce significant effects on any measure of the light-
evoked responses that were measured during performance of the modified visual 
signal detection task.  MPH (2 mg/kg, ip) showed a trend towards decreasing the 
latency to the onset of response (median of differences = -2, p = 0.09; Figure 25I) 
and significantly decreased the latency to reach the maximum peak amplitude 
(median of differences = -3, p < 0.05; Figure 25J).  The 2 mg/kg dose of MPH 
also showed a trend to increase the maximum amplitude of the response 
(median difference = 3.7, p = 0.07; Figure 25K) without having an effect on the 
response peak area (Figure 25L).   
Percent change across treatment days   
MPH broadly affected the properties of single-unit responses to light 
stimuli during performance of the modified visual signal detection task similar to 
the effects observed on multi-unit activity when evaluated across treatment test 
days.  MPH significantly affected the latency of the response onset (H = 73696, p 
= 0.0213; Figure 26A) with Dunn’s multiple comparisons test revealing that the 2 
mg/kg decreased the latency compared to control.  Although trends to decrease 
the latency to the maximum peak response and increase the maximum peak 
amplitude were apparent and resembled MPH’s effects observed on the multi-
unit activity, these measures did not reach significance (H = 3.139, p = 0.2081; 
Figure 26B) and (H = 0.8750, p = .6457; Figure 26C), respectively.  Again, there 
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were no effects on the response peak area following MPH treatment (H = 0.2413, 
p = 0.8864; Figure 26D).   
Taken together, MPH-induced facilitation of dLGN single unit responses to 
light cues during performance of the visual signal detection task were not as 
profound as those observed in multi-unit recordings taken simultaneously from 
the same animals under the same experimental conditions (Figure 23).  
However, MPH effects on the latency to reach the maximum peak and the 
amplitude of the peak response both tended to follow the same pattern and 
direction as MPH effects on the multi-unit measures.  We presume that our lack 
of significant effects following MPH administration on these measures derives 
from the increased difficulty of isolating activity from single neurons in behaving 
animals over time and between sessions, thus leading to a smaller sample size 
of dLGN cells in this paradigm.  Nevertheless, when these changes were 
observed, the facilitating effects of MPH on the response properties of individual 
cells were robust as evidenced in Figure 24.   
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Figure 24.  Representative example of MPH effects on single-unit activity 
during performance of the modified visual signal detection task.  PSTHs 
illustrate the effects MPH treatment on responses of a single unit within the 
dLGN.  Histograms are aligned to stimuli onset (time = 0) during pre-treatment 
control (top; saline) and drug post-treatment (bottom; MPH 2 mg/kg) conditions.  
Spike rate intensities represented as frequency in impulses/second (imp/sec) are 
plotted using bin widths of 1 msec with boxcar smoothing across 3 adjacent bins. 
Green dashed line: an example of decreased latency to response onset following 
drug post-treatment.  Blue dotted line: an example of decreased latency to peak 
response following drug post-treatment.  An increase in the maximum peak 
amplitude is apparent across the pre- and post-MPH PSTHs.   
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Figure 25.  MPH effects on properties of visually-evoked responses in the 
dLGN within treatment test days.  Bivariate scatter plots represent vehicle on 
the x-axis by MPH on the y-axis values for properties of neuronal activity in 
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response to light stimuli following saline (A – D), MPH 0.5 mg/kg, ip (E – H), and 
MPH 2 mg/kg, ip (I – L).  Points clustering above the 45 degree equivalence line 
indicate that there was increase in the response measure following MPH 
treatment whereas those below the line indicate that there was a decrease in the 
response measure following MPH treatment.  * below the line of identity denotes 
a significant decrease (p < 0.05) in measures post-MPH treatment. 
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Figure 26.  MPH effects on single-unit activity during performance of a 
modified visual signal detection task.  Line graphs represent percent change 
values for properties of dLGN single-unit neuronal activity in response to light 
stimuli following a dose response MPH (vehicle n = 28 cells, 0.5 mg/kg n = 25 
cells, 2 mg/kg n = 31 cells).  A and B.  Latency to response onset and maximum 
peak response measured in milliseconds (ms), respectively.  C and D.  Maximum 
peak amplitude and response peak area measured in impulses/second (imp/s).   
* denotes significant differences (p < 0.05) from vehicle in Dunn’s multiple 
comparisons following an overall effect in Kruskal-Wallis tests. 
 
A 
C 
B 
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Discussion 
The studies described in this chapter investigated the effects of MPH on 
light-evoked activity within the dLGN of rats performing a modified visual signal 
detection task.  This task was specifically designed to simultaneously evaluate 
electrophysiological correlates of early stage sensory processing and measures 
of performance during signal detection behavior.  In the previous chapter, we 
showed that MPH (2 mg/kg, ip) enhanced behavioral performance in the task by 
increasing the speed of reaction times to make correct responses.  Here, we 
successfully recorded multi- and single-unit activity from electrode bundles in the 
dLGN of rats performing the modified visual signal detection task.  The major 
finding from this experiment is that the same dose of MPH (2 mg/kg) that 
enhanced behavioral performance also enhanced measures of stimulus light-
evoked neuronal discharge. 
When recording neuronal activity from waking animals trained to perform 
behavioral tasks it is crucial to capitalize on all possible resources of interpretable 
and meaningful information for as long electrode implants remain viable.  A 
prevailing trend across in vivo extracellular recording studies has been to 
overestimate the significance of sampling activity from single cells and 
underestimate the significance of also sampling from ensembles of neurons.  
Multi-unit data is an often overlooked measure that allows the study of 
experimental manipulations on neuronal responsiveness over a representative 
population of cells within a specified circuit or neural network as opposed to 
individual unit activity.  In most cases, multi-unit activity has been shown to 
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reflect the activity and the changes in activity that occur at the single unit level 
(Devilbiss and Waterhouse, 2002).  It may in fact be the case that ensembles of 
neurons are a more accurate representation and key to understanding the 
dynamics of information processing in brain regions of waking animals during 
performance of complex behavioral tasks (Devilbiss and Waterhouse, 2002, 
Nicolelis and Lebedev, 2009).  Nicolelis and Lebedev reviewed these principles 
and argued the importance of investigating the dynamics of ensemble neuronal 
activity in addition to evaluating single neuron discharges to more 
comprehensively understand the physiological operations of the brain in the 
waking state.  Correspondingly, it is within the multi-unit activity of our data that 
we realized the greatest benefit of MPH on light stimulus-evoked neuronal 
discharge within the dLGN of rats performing the visual signal detection task.  
Although we observed the same patterns of drug induced enhancement in 
analysis of single-unit data, MPH produced the most dramatic and consistent 
effects on dLGN ensemble responses to light stimuli during task performance.   
MPH-induced enhancement of light-evoked activity within the dLGN of rats 
performing the modified visual signal detection task spanned multiple response 
properties.  The 2 mg/kg dose of MPH significantly decreased the onset latencies 
of both multi-unit and single-unit responses to light stimuli.  This dose also 
significantly reduced the latency to reach the maximum peak response of multi-
units, while trending to reduce the peak latency of single units.  Although not as 
prominent as observed with behavioral latencies to make correct responses as 
reported in Chapter 5, a general slowing of response latencies in the control 
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condition is evidenced in Figures 23 and 26 during the second run of the task.  
We attribute these effects to a slight decrease in overall motivational and arousal 
state during performance of the second run of the task on test days.  Decreases 
in response latencies to sensory stimulation following MPH administration are 
analogous to those observed within the anesthetized preparation in the rat dLGN 
as reported in Chapter 4 and Navarra et al. (2013) and also previously described 
within the somatosensory cortex of anesthetized rats (Drouin et al., 2007).  
These parallel findings suggest that MPH is capable of speeding responsiveness 
to stimulus driven inputs in sensory processing areas of the brain under both 
anesthetized and waking conditions.  Interestingly, response latencies of sensory 
neurons have been shown to be influenced by top-down attention mechanisms 
within the V4 visual area of monkeys performing a targeted cue task (Sundberg 
et al., 2012).  In this study, monkeys were instructed to fixate on a central 
location and covertly focus attention to a target stimulus surrounded by distractor 
stimuli.  Target and distractor stimuli randomly appeared within or outside of the 
receptive field of the neurons recorded.  Attention decreased response latencies 
to target stimuli as compared to non-target stimuli.  The authors suggest that 
attention reduces response latencies of visual cortical neurons by depolarizing 
them, creating a “ready state” prior to the arrival of an expected afferent input so 
they are closer to spiking threshold when targets appear in the receptive field.  
This action would reduce the time required for the neuron to respond upon the 
arrival of stimulus.  The data from the current studies provide compelling 
evidence that MPH may produce a condition that mimics the effects of top-down 
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attention to stimuli.  Indeed, MPH is routinely used in the clinic to improve 
attention in ADHD patients, so it seems fitting that MPH administration produces 
similar effects on the processing of sensory information as compared to a natural 
states of attention.  It may be the case that MPH creates an attention-like mode 
of operation within sensory processing areas of the brain that simulates 
“readiness” for processing sensory stimuli in either the anesthetized (see Chapter 
4) or waking state.   
In addition to reducing the response latencies within the dLGN of rats 
performing the modified visual signal detection task, MPH dose-dependently 
increased the peak amplitude of multi-unit responses to target stimuli without 
exerting a consistent effect on the peak area.  In another study employing a 
selective attention task, McAlonan et al. (2008) found that while monkeys 
remained fixated on a central location, LGN activity was greater in amplitude to 
covertly attended stimuli  relative to unattended stimuli appearing within receptive 
fields.  These data provide further evidence that MPH produces attention-like 
effects on various dimensions of sensory neuron response properties.   
The effects of systemically administered MPH on response magnitudes 
and response latencies of sensory neurons to afferent inputs in anesthetized and 
waking animals strongly resemble previously demonstrated influences of the 
locus coeruleus–norepinephrine (LC-NE) transmitter system.  It was shown long 
ago that electrical stimulation of the LC or local iontophoretic application of NE 
can facilitate dLGN neuronal responses to retinal inputs in anesthetized rats 
(Kayama, 1985, Kromer and Moore, 1980, Rogawski and Aghajanian, 1980a, b).  
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Given that MPH blocks the reuptake of NE and increases extracellular levels of 
the neurotransmitter throughout the brain, our observed augmentation of peak 
amplitudes as well as reduction of peak latencies in response to visual stimuli are 
consistent with the well documented modulatory actions of the noradrenergic 
system in sensory regions of the brain.  In this regard it is worth noting the 
possibility that increased response amplitudes observed in multi-unit data could 
be in part due to gating of previously unresponsive dLGN neurons which is 
another characteristic feature of NE-mediated effects in sensory circuits 
(Devilbiss and Waterhouse, 2011, Waterhouse et al., 1988).  However, we did 
not find any evidence of gating within the single-unit data and cannot draw any 
firm conclusions about the impact of gating on multi-unit responses with the 
present information.       
MPH did not produce significant effects on the response peak area in 
either multi-unit or single-unit data within these experiments, although peak 
amplitudes were clearly increased.  While these findings are counterintuitive, it is 
important to note that NE-mediated effects on sensory neurons are not only 
represented by facilitation of excitatory responses, but by augmentation of 
inhibitory responses as well (Waterhouse et al., 1990).  It can be observed in the 
representative PSTHs shown in Figure 22, MPH administration sharpened the 
boundaries of the light-evoked response as compared to the above PSTH with 
saline on board.  In the PSTH from the saline-treated condition, the response 
peak slowly ramps up and continues to trail off after reaching maximum 
amplitude, whereas the PSTH from the MPH-treated condition has a clear 
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termination of the response peak after reaching the maximum amplitude.  From 
this example, it seems MPH is changing the structure of the light-evoked 
response by decreasing the duration of the response so that it is more focused, 
which is also a feature of NE-mediated effects on sensory processing neurons 
(Drouin et al., 2007).   
It is well to remember that the observed facilitating effects of MPH were 
observed in normal laboratory rats as opposed to an ADHD model.  As such, 
these effects may help explain the prevalence of off-label use of 
psychostimulants for their performance enhancing effects in healthy individuals.  
In all likelihood, MPH is engaging the intrinsic noradrenergic physiological 
mechanisms to enhance the normal signal processing operations of neurons and 
neural circuits that impact performance.    
Taken together, MPH-induced enhancement of responses to light stimuli 
in behaving animals suggests that sensory enhancement of early stage sensory 
signal processing is a significant component of the performance enhancing 
effects of MPH.  Accordingly, the 2 mg/kg dose of MPH, which produced the 
greatest facilitation on light-evoked neuronal responsiveness, also enhanced 
behavioral performance of the modified visual signal detection task by improving 
reaction times to make correct responses.  MPH-induced enhancement of early 
stage signal processing may trigger a domino effect throughout the visual 
processing stream and further into the behavioral outcomes during goal-directed 
performance.  As such, greater efficiency in processing visual information within 
the dLGN has been shown to strengthen the dynamics of synaptic transmission 
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to the visual cortex, thus increasing information transfer to cortical targets and 
facilitating higher order processing of visual signals (Alonso et al., 1996, 
Saalmann and Kastner, 2009, Swadlow and Gusev, 2001).  This early facilitation 
of visual processing may lead to improvements in overall behavioral outcomes 
during performance of the visual signal detection task. 
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CHAPTER 7 
AIM 4: Determine the effects of methylphenidate on visually-evoked 
potentials in response to light stimuli within the dLGN of rats performing a 
visual signal detection task 
 
Rationale 
The previous chapters reported the effects of MPH on light-evoked unit 
activity in response to target stimuli during performance of a visual signal 
detection task and behavioral outcomes.   We found that MPH enhanced the 
speed and strength of light-evoked neuronal responses to light stimuli and that 
these effects paralleled improved behavioral performance within the task.  Here, 
we investigated the effects of MPH on an additional measure of early stage 
sensory signal processing within the dLGN, the local field potential (LFP).   
LFPs are used to measure changes in electrical potential driven by 
synaptic activity within a local population of neurons and can be recorded 
simultaneously from the same electrodes as those used to record unit activity 
(Buzsáki et al., 2012).  A visual evoked potential (VEP) is an LFP that is time-
locked to the onset of a given visual stimulus and is used to evaluate changes in 
local circuit responsiveness to that stimulus.  VEPs are characterized by peaks 
and troughs in the LFP from which amplitude and latency measures can be 
calculated.  VEPs can be used as a complimentary measure of sensory signal 
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processing in addition to unit data.  Interestingly, it was shown recently that top-
down influences of selective attention decreased latencies of the first deflection 
of VEPs within the visual cortex of monkeys performing a targeted cue task 
(Sundberg et al., 2012).  These findings prompted investigation of whether MPH 
might also improve response latencies of the dLGN VEP to target stimuli during 
performance of the modified visual signal detection task.  In order to test this 
idea, VEPs were recorded from the dLGN of behaving animals before and after 
administration of MPH.  We postulated that MPH would enhance visually-evoked 
responses to light stimuli within the dLGN and that these effects will positively 
correlate with improved performance in the signal detection task.   
 
Specific materials and methods 
VEPs were recorded simultaneously with single- and multi-unit data from 
subjects performing the modified visual signal detection task and the properties 
of these waveforms were evaluated according to the same experimental design 
as described for unit data.  Briefly, MPH was administered (0.5 and 2 mg/kg, ip, 
15 mins prior to performance in the task).  Test days consisted of two runs of the 
task in which the first run followed vehicle administration and the second run 
followed a counter-balanced drug dosing design where all rats received all doses 
of MPH or vehicle.  This design allowed various components of the VEP 
response for each channel of LFP data recorded to be compared to itself on a 
given day and expressed as a modulation ratio [(post-treatment – pre-
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treatment)/pre-treatment x 100].  Drug-induced changes were then compared 
across each dose of MPH.   
VEPs in response to light stimuli during performance of the visual signal 
detection task were constructed using NeuroExplorer (Plexon).  Similar to 
thalamic VEPs previously reported by Meeren et al. (1998), we found that VEPs 
recorded in rats performing the modified visual signal detection task generally 
exhibited a prominent P30, a positive deflection of the waveform occurring 30 
msec after the onset of target stimulus presentation, and an N54, a negative 
deflection of the waveform occurring 54 msec following the onset of stimulus 
presentation.  Accordingly, we adopted this nomenclature to describe these 
components of the VEP response.  Custom matlab routines were utilized to 
detect the latency and amplitude of the P30 and N54.   
 
Methylphenidate-induced modulation of visual evoked potentials within the dLGN 
of rats performing a modified visual signal detection task 
The effects of MPH (0.5 and 2 mg/kg, ip, 15 mins prior to task 
performance) on VEPs to light stimuli within dLGN were evaluated (vehicle n = 
14 channels, 0.5 mg/kg n = 15 channels, 2 mg/kg n = 18 channels).  We found 
that VEPs exhibited prominent P30 and N54 components similar to VEPs 
described previously in rat thalamus (Meeren et al., 1998).  Kruskal-Wallis tests 
were conducted to compare percent changes for latency and amplitude 
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components of the VEP response across doses and Dunn’s multiple 
comparisons were investigated following an overall effect.  
VEPs were averaged from light-responsive channels across all 6 rats and 
represented in two time scales in order to represent changes in latency and 
magnitudes of the waveform in Figure 27A – C (expanded timescale shown in 
insets).  MPH administration produced significant effects on the latency of the 
P30 waveform (H = 9.156, p = 0.0103; Figure 27D) with Dunn’s multiple 
comparisons revealing a significant reduction in the P30 latency at the 2 mg/kg 
dose as compared to saline control.  MPH at 2 mg/kg also produced significant 
effects on the amplitude of the P30 (H = 7.611, p = 0.0222; Figure 27E) with 
Dunn’s multiple comparisons revealing a drug mediated decrease in amplitude of 
the P30 as compared to saline control. There were no significant effects on either 
the latency or the amplitude of the N54 (H = 1.747, p > 0.05; Figure 27F and H = 
2.787, p > 0.05; Figure 27G, respectively).   
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Figure 27.  MPH effects on visual evoked potentials of the visual signal 
detection task.  Normalized average evoked LFP in response to visual cues and 
percent change values for properties of VEPs during performance in the visual 
signal detection task.  A – C:  Representative VEPs were averaged from light-
responsive channels across all 6 rats (A; saline n = 14 channels, B; MPH 0.5 
mg/kg n = 15 channels, and C; MPH 2 mg/kg n = 18 channels).  Note that VEPs 
recorded in rats performing the modified visual signal detection task generally 
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exhibited a prominent P30, a positive deflection of the waveform occurring 30 
msec after the onset of target stimulus presentation, and an N54, a negative 
deflection of the waveform occurring 54 msec following the onset of stimulus 
presentation.   Waveforms were plotted using bin widths of 1 msec for the full 
VEP waveform and insets show expanded timescales (20 – 40 msec) to highlight 
differences observed at the P30 response.  D – G: Line graphs represent percent 
change values for properties of VEP waveforms to light stimuli following a dose 
response MPH.  D and F:  Latency to P30 and N54 responses measured in 
milliseconds (msec), respectively.  E and G:  Amplitude of P30 and N54 
responses measured in millivolts.   * denotes significant differences (p < 0.05) 
from vehicle in Dunn’s multiple comparisons following an overall effect in 
Kruskal-Wallis tests.  
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Discussion 
MPH (2 mg/kg) reduced the latency and amplitude of the first positive 
deflection, i.e. P30, of the VEP response.  It is generally accepted that P30 
represents the primary excitation peak of the VEP response and the first 
prominent indication of signal transmission within the dLGN (Meeren et al., 
1998).  A reduction in P30 latency suggests visual signals associated with the 
modified visual signal detection task are being transmitted to the dLGN more 
quickly following MPH administration as compared to controls.  
P30 latencies recorded during the second run of the task following 
administration of either saline or the 0.5 mg/kg dose of MPH increase in latency 
suggesting that signal transmission is inherently not as fast during the second 
run of the task (inset of Figure 27A and B).  This observation is not exclusive to 
the P30 component of the VEP when considered in the context of other 
behavioral and electrophysiological measures as reported in Chapters 5 and 6.  
These effects are likely a result of our task design, where a slight decrease in 
motivational and arousal state may affect VEPs in response to light stimuli during 
the second run of the task.  Nonetheless, the 2 mg/kg dose not only prevented 
this general slowing of signal transmission within the dLGN during performance, 
but in fact reversed these effects and decreased the latency to reach the P30.    
We also observed the 2 mg/kg dose of MPH decreased the amplitude of 
the P30 response as compared to the saline control.  Although in terms of signal 
processing and transmission throughout sensory areas of the brain it is usually 
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expected that ‘bigger equals better’ in terms of sensory evoked responses, the 
current results require further consideration.  Similar effects were observed in the 
visual cortex of monkeys performing a targeting cue task by Sundberg et al. 
(2012), where selective attention decreased both the latency and the magnitude 
of the first deflection of the VEP.  Bearing these results in mind, it appears MPH 
effects on dLGN VEPs mimic top-down influences of selective attention on VEPs 
recorded from monkey visual cortex.  The authors of this study provided an 
interesting theory to explain decreases in both latency and magnitude of the first 
deflection of VEPs in the context of their unit data results.  The LFP waveform is 
influenced by magnitude, sign, spatial proximity, and temporal coordination of 
current sources and it is generally accepted that postsynaptic potentials 
contribute most heavily to the LFP.  As such, attentional influences could place 
the aroused brain in an alerted state so that target stimuli trigger an already 
“primed” sensory processing circuit that results in quicker response latencies.  
They argue that since the primed or “ready” state is established before the arrival 
of afferent input, less change in magnitude of the initial deflection of the VEP is 
observed because less synaptic driving force is needed to elicit the neuronal 
response from responsive neurons in this ready state. It may be reasonable to 
extend the same explanation to the effects we’ve observed in the dLGN following 
MPH administration given the drug’s well described biochemical and attention-
enhancing effects.  For example, MPH mediated blockade of catecholamine 
reuptake leads to elevated extracellular concentrations of NE and dopamine, 
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which via their modulatory actions may serve to prime sensory circuits for receipt 
of stimulus-driven afferent input.   
One additional report describes the effects of systemically administered 
MPH on VEPs (Hetzler et al., 2014).  In this study the amplitude of light evoked 
VEPs recorded from superior colliculus and visual cortex of waking rats were 
reduced following MPH administration while VEP latencies were increased.  
Thus, the results of these studies agree with the present findings in terms of 
reduced VEP amplitudes but not with respect to drug effects on VEP latencies.   
However, direct comparison of the findings from these studies is complicated by 
differences in experimental design.  The study by Hetzler et al. (2014) reported 
differences in amplitude and latency for much later components of the VEP than 
P30 and N54.   Moreover, in the work by Hetzler et al. (2014) animals were 
placed in test chambers and presented with light stimuli that had no behavioral 
significance.  Likewise, stimuli were delivered randomly from outside of the 
chamber raising questions about the animals’ state of arousal throughout the test 
period and the accuracy and repeatability of stimulus presentation from a fixed 
point in visual space.   
Another interesting aspect of the 2 mg/kg of MPH’s effect on VEPs was a 
trend to increase the magnitude of the N54 response (Figure 27C and G).  The 
N54 component of thalamic VEPs is considered to be a representation of 
synaptic inhibition resulting from activation of GABAergic inputs from the thalamic 
reticular nucleus (Meeren et al., 1998).  If VEPs measured within the dLGN do in 
fact correspond to underlying synaptic events at the level of single cells, then 
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increases in N54 may reflect the increased post-excitatory inhibition observed in 
multi-unit responses following MPH administration.    
In summary, MPH decreased the latency and magnitude of the first 
deflection of the VEP in response to light stimuli during performance of the 
modified visual signal detection task.  These effects were observed at the same 
dose that enhanced measures of behavioral performance and neuronal 
responsiveness to target light stimuli.  These results are consistent with faster 
sensory signal processing and better visual signal detection. 
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CHAPTER 8 
AIM 5:  Determine the neurochemical identity of catecholaminergic 
inputs to the rat dLGN 
 
Rationale 
The experiments in Aims 1-4 showed that systemic methylphenidate 
(MPH) administration can enhance light-evoked neuronal responses and VEPs 
within the dLGN of intact rats under both anesthetized and waking conditions.  In 
the waking condition, dLGN responses to target lights during performance of the 
modified visual signal detection task were improved in multiple ways.  First, 
latencies to response onset and to the peak of the primary response were 
decreased.  Second, the peak intensity of stimulus evoked single- and multi-unit 
discharge was increased.  These findings indicate that both the speed and 
strength of signal transmission through the dLGN was improved during task 
performance.  In addition, the time to reach the first peak of the VEP response to 
target stimuli within local field potential (LFP) recordings was decreased, 
indicating that the first signal representing the processing of target cues within 
the dLGN during task performance occurred at shorter latencies following MPH 
administration.  In summary, we observed MPH-induced enhancement of single-
unit, multi-unit, and VEP responses to target light cues during performance of a 
modified visual signal detection task.  These changes in signal processing were 
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observed at the same dose of MPH (2 mg/kg, ip) that enhanced behavioral 
performance, as indexed by reduced reaction times for making correct responses 
within the task.  Given the ability of MPH to improve cognitive performance in 
humans and rodent assays of attention, these results suggest that augmentation 
of sensory transmission at early stages of signal processing may be a significant 
component of the performance enhancing effects of psychostimulant drugs, such 
as MPH.   
The effects of MPH on dLGN neuronal responses to light stimuli in 
anesthetized and waking animals are strikingly similar to the well documented 
modulatory effects of NE or locus coeruleus (LC)-NE pathway activation on 
individual neuron and neural circuit responses to afferent synaptic inputs 
(Berridge and Waterhouse, 2003).  Hence, the proposal that the observed 
facilitating actions of MPH on sensory signal processing in the dLGN are 
mediated by NE.  There are at least two lines of evidence to support this 
contention.  First, the LC-NE system is believed to play a major role in regulating 
behavioral state and state-dependent sensory processing (Berridge and 
Waterhouse, 2003).  Second, the dLGN receives substantial noradrenergic 
innervation from the LC (Kromer and Moore, 1980, Latsari et al., 2004, 
Papadopoulos and Parnavelas, 1990), placing this early stage sensory 
processing circuit in a prime position for expression of LC-NE modulatory 
influences.  Nonetheless, MPH blocks reuptake of both NE and dopamine (DA), 
so possible dopaminergic influences on dLGN signal processing cannot be 
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completely discounted despite previous reports suggesting dopaminergic 
innervation of dLGN is sparse or non-existent (García-Cabezas et al., 2009).  
To further explore the potential role of dopamine in MPH mediated 
enhancement of dLGN sensory signal processing, sections through the dLGN 
were immunostained for tyrosine hydroxylase (TH) and dopamine β-hydroxylase 
(DBH), enzymes responsible for synthesis of DA and NE, respectively. Fibers 
that stain for TH-only are dopamine containing, whereas fibers that stain positive 
for TH and DBH are NE containing. A priori the prediction was that all axons 
would stain positive for TH and DBH, thus identifying them as NE containing and 
confirming the absence of DA innervation to the dLGN.  Such a result would 
demonstrate that MPH actions within the dLGN are mediated by NE and not 
dopamine neurotransmission.   
 
Specific materials and methods 
To examine the expression of DBH and TH expression in the rat dLGN, 
double fluorescent immunohistochemical techniques were used.  Brains of three 
rats were sliced through the dLGN along the coronal plane with a freezing 
microtome at 40 microns. The tissue was permitted to freely float in small wells 
and sections were selected that spanned the anterior/posterior length of the 
dLGN.  Sections were first rinsed several times in 0.1 M PBS. To visualize TH 
expression, tissues were blocked in Normal Donkey Serum (Sigma-Aldritch, St. 
Louis, MO) in PBST (4% NDS, 0.3% Triton-X, 0.1 M PBS) for 90 minutes and 
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then processed for 48 hours (in a cold room at 4 degrees C) in anti-rabbit TH 
antibody (1:500, Millipore, Temecula, CA). They were then rinsed several times 
in PBS and then visualized using with donkey anti-rabbit Alexafluor 594 (1:250; 
Invitrogen, Eugene, OR) for 1 hour at room temperature in the dark. To visualize 
DBH expression in the same tissue, sections were then rinsed several times in 
PBS and then blocked in Normal Goat Serum (Sigma-Aldritch, St. Louis, MO) in 
PBST (6% NGS, 0.3% Triton-X, 0.1 M PBS) for 90 minutes and then processed 
for 48 hours (in a cold room at 4 degrees C) in anti-mouse DBH antibody (1:500, 
Chemicon, Temecula, CA). After several rinses in PBS, sections were then 
visualized with goat anti-mouse Alexafluor 488 (1:250, Invitrogen, Eugene, OR) 
for 1 hour at room temperature in the dark. Finally, sections were reorganized 
and mounted on gelatin-coated glass slides and covered.  Digital 
photomicrographs of sections were taken using a DM RBE microscope (Leica 
Microsystems) equipped with a Retiga EXi Fast 1394 Monochrome Cooled 12-bit 
camera and QCapture Image Processing software (QImaging). 
 
Catecholaminergic input to the rat dLGN 
Examination of serial sections through the rat dLGN of each animal (n = 3) 
revealed an abundant distribution of fibers containing both TH and DBH, but no 
evidence of TH only fibers.  This observation was confirmed when the images 
were merged for further visual inspection.  Figure 28 shows representative 
examples of TH and DBH co-localization within the dLGN. 
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Figure 28.  Immunohistochemical staining of TH and DBH expressing fibers 
in dLGN. Tyrosine hydroxylase expression (TH; red) is shown in A1-A3, 
dopamine β-hydroxylase expression (DBH; green) is shown in B1-B3, and C1-C3 
represents a merge of previous images.  Arrows point to representative fibers co-
expressing the two proteins. A1-C1 images are captured at 20x magnification.  
Rectangles in A1-C1 are magnified to 40x and scaled in subsequent images.  In 
merged images, note the presence of TH expressed only in fibers also 
expressing DBH, concluding that there was no evidence of dopaminergic 
innervation in the dLGN brain region. 
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Discussion 
The present results suggest that catecholaminergic innervation of the rat 
dLGN is solely noradrenergic, thus verifying previous reports indicating that 
dopaminergic input to the dLGN is either sparse or non-existent (García-Cabezas 
et al., 2009).  First, TH- and DBH-positive fibers were identified within the dLGN.  
Next, all TH-positive axons were shown to be positive for DBH.  Co-localization 
of TH and DBH within axons strongly suggests that fibers are noradrenergic, and 
not dopaminergic (Nagatsu, 1991).   Furthermore, the presence of DBH, the 
enzyme that converts DA to NE, is a classical and exclusive phenotype of 
noradrenergic neurons.  Comprehensive inspection of catecholaminergic fibers 
within the dLGN produced no evidence of axons containing TH without also 
containing DBH.   
These data indicate that all catecholamine-containing fibers within the rat 
dLGN are exclusively noradrenergic.  Given MPH blocks reuptake of NE and DA, 
the absence of dopaminergic fibers terminating within the dLGN suggests that 
the observed MPH-induced modulation of light-evoked activity within the nucleus 
is mediated locally by NE, and not DA neurotransmission.  These data do not 
rule out the possibility of dopamine-mediated effects of MPH that occur remote to 
the dLGN but nevertheless are capable of impacting the transmission of visual 
signals through the nucleus. 
Although there have been limited reports claiming that DA release is 
possible from noradrenergic terminals originating from the LC, these findings 
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relied on manipulations of catecholaminergic transmission that are likely outside 
the context of the present experiments (Devoto et al., 2014, Devoto et al., 2005a, 
b, Devoto et al., 2015, Smith and Greene, 2012).  For example, Smith and 
Greene (2012) showed that amphetamine could induce DA release from LC 
neurons within the dorsal hippocampus.  Part of amphetamine’s mechanism of 
action is to increase DA release through DAT-mediated reverse transport (dela 
Pena et al., 2015, Espana and Jones, 2013).  Given the ability of NET to 
transport DA in areas of low DAT expression such as the PFC (Bymaster et al., 
2002, Carboni et al., 1990, Madras et al., 2005, Swanson et al., 2006), it may be 
possible that NET is also capable of reverse transport of recently reabsorbed DA 
from the extracellular space.  However, reverse transport is not an identified 
mechanism of MPH and the relevance of these findings with respect to 
endogenous catecholamine release and uptake within the thalamus remains 
unknown.  In addition, Devoto et al. (2005a, 2005b, 2014, 2015) showed that 
DBH inhibition increased extracellular DA through noradrenergic terminal release 
within the PFC.  Although these findings are interesting, such a fundamental 
disruption of the LC-NE system is beyond the scope of the physiological 
conditions that were evaluated in the present experiments.     
There have also been limited accounts of the ability of DA to alter dLGN 
neuronal function in response to optic tract stimulation, but these studies focused 
on the receptor-mediated mechanisms underlying the observed alterations and 
their findings are conflicting (Albrecht et al., 1996, Govindaiah and Cox, 2005, 
2006a).  For example, Govindaiah and Cox (2005, 2006) presented evidence for 
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excitatory actions of D1 receptor activation and inhibitory actions of D2 
stimulation, whereas Albrecht (1996) revealed the opposite for both DA receptor 
subtypes.  In light of these reports, it has been shown that only D1 and not D2 
receptors are expressed within the rat dLGN (Wamsley et al., 1989), further 
complicating the interpretation of these data.  Although we cannot completely 
rule out possible actions of endogenously released DA playing a role in MPH-
induced sensory enhancement within the rat dLGN, this possibility lacks 
compelling evidence as compared to the known sensory-facilitating effects of 
enhanced noradrenergic transmission.   
This work suggests that MPH, acting via noradrenergic mechanisms, can 
substantially impact early stage sensory signal processing, an effect that could 
positively influence responses to stimuli in ADHD patients and healthy individuals 
seeking performance enhancement.   
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CHAPTER 9 
CONCLUDING REMARKS 
 
Findings and conclusions 
The overarching hypothesis tested in the current work was that 
psychostimulant agents, such as MPH, improve sensory processing of incoming 
stimuli by enhancing noradrenergic transmission, an effect which contributes to 
the performance enhancing effects of these agents.  As such, it was proposed 
that MPH would facilitate early stage sensory signal processing and behavioral 
outcomes during performance of a visual signal detection task.  A combination of 
electrophysiological, behavioral, and histochemical methods was used to 
address specific hypotheses linking cellular and circuit functions with behavioral 
performance.  In Aim 1, it was demonstrated that MPH improved the speed and 
strength of neuronal responsiveness to light stimuli within the dLGN of 
anesthetized rats and that full enhancement of signal transmission was 
dependent on blockade of NE reuptake.  In Aim 2, MPH improved behavioral 
performance of rats in a visual signal detection task by decreasing reaction times 
to make correct responses.  Aims 3 and 4 demonstrated that electrophysiological 
measures of signal processing of target light stimuli were facilitated within the 
dLGN during performance of the visual signal detection task.  Aim 5 confirmed 
that all catecholaminergic fibers within the dLGN are solely noradrenergic, further 
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indicating that enhanced NE neurotransmission underlies the modulatory effects 
of MPH within this nucleus.  This work supports the overall hypothesis that MPH 
facilitates early stage sensory signal processing during goal-directed behavior 
through noradrenergic mechanisms and that sensory enhancement is a 
significant component of psychostimulant-induced performance enhancement.   
 
MPH mimics NE-mediated modulation of sensory processing circuits 
MPH enhanced dLGN responsiveness to light stimuli in a variety of ways 
including decreased response latencies, increased response magnitudes, and 
gating of responses to previously subthreshold sensory input.  Similar alterations 
of stimulus-driven responses within thalamic and cortical areas involved in 
sensory processing pathways by increased NE neurotransmission suggest that 
MPH-induced sensory enhancement is similar if not identical to NE-mediated 
modulation of sensory-evoked responses.   
The speed of signal processing within the dLGN was enhanced in the 
anesthetized state and during performance of a visual signal detection task 
following MPH administration.  Latencies to reach the response onset and the 
maximum peak response as determined from peri-stimulus time histograms 
(PSTHs) were decreased.  The latency to reach the first deflection within the 
VEP response was also decreased.  Decreases in latency indicate that the 
neural mechanisms activated within dLGN in response to light stimuli are 
engaged more quickly following sensory stimulus presentation.  This was 
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observed at the cellular level and within the local field potential.  Decreases in 
response latency have previously been observed when concentrations of NE 
were elevated within sensory circuits by tonic stimulation of the LC (Devilbiss and 
Waterhouse, 2004).  In this report, temporal properties of stimulus-evoked 
responses within the thalamus and cortex were reduced by 1 – 3 msec, which is 
in line with the changes in latency observed in the current work.  Thus, MPH 
administration mimics the effects of increased NE neurotransmission on the 
latency of stimulus-evoked responses to incoming sensory stimuli. 
The magnitude of stimulus-evoked responses to light stimuli was 
increased by MPH administration in both anesthetized and waking conditions.  In 
the anesthetized rat, both the amplitude of the maximum peak response as well 
as the peak response area were augmented.  Early work by Rogawski and 
Aghajanian (1980a) in the anesthetized rat demonstrated that both LC 
stimulation and local iontophoretic application of NE enhanced synaptic 
excitation of dLGN neurons in response to optic chiasm stimulation.  MPH-
induced amplification of dLGN responses to light stimuli clearly mimics the 
previously demonstrated effects of increased dLGN concentrations of NE on 
responses to afferent pathway electrical stimulation. In rats performing the visual 
signal detection task, the amplitude of the maximum peak response was also 
increased.  Similar effects on ventroposterior medial (VPM) thalamic and barrel 
field cortical neuronal responses upon whisker pad stimulation were observed in 
waking rats during tonic activation of the LC (Devilbiss and Waterhouse, 2004).  
The similarity of outcomes resulting from MPH administration as compared to LC 
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stimulation indicate that MPH produces NE-like amplification of neural signals 
across both anesthetized and waking states.  However, it is important to 
remember that local tissue concentrations of NE following systemic MPH 
administration versus LC stimulation have not been determined, thus limiting 
direct comparisons of putative NE actions. Moreover, given previous reports and 
the current work, it is still unclear whether NE-mediated amplification of sensory 
signals is dependent on task relevance of stimuli.  Although Devilbiss and 
Waterhouse (2004) evaluated NE-mediated modulatory effects on sensory driven 
responses in thalamic and cortical circuits of the waking animal, the whisker pad 
stimulation employed in that study had no relevance for the rat as a specified 
task-related signal in a goal-directed behavior.  As such, it would be interesting to 
measure the effects of LC stimulation on sensory responses within the VPM and 
barrel field cortex if rats were required to use whisker stimulation as a cue for 
completing a goal-directed task.  Importantly, the current work is the first to 
demonstrate drug-induced NE-like modulation of light-evoked responses to 
stimuli necessary for goal directed performance within a visual signal detection 
task.  Further studies to dissociate effects on signals that are irrelevant versus 
relevant to task performance are warranted and discussed further in Future 
directions (see below).   
In the anesthetized rat, dLGN cells that were initially unresponsive to a 
given stimulus intensity exhibited a prominent response to that same intensity 
stimulus following MPH administration.  Such “gating” of sensory-evoked 
neuronal responses is a characteristic feature of NE-mediated effects in sensory 
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circuits.  For example, previous reports indicate that LC electrical stimulation or 
local iontophoretic application of NE can prompt cellular responses to otherwise 
subthreshold synaptic inputs within thalamic and cortical sensory circuits 
(Devilbiss and Waterhouse, 2004, Waterhouse et al., 1988).  As such, gating 
represents yet another dimension of NE action on sensory signal transmission 
that was observed following MPH administration.  Although evidence of gating 
was not found under waking conditions in the current work, it is possible that 
increased response amplitudes observed in multi-unit data could be in part due 
to gating of previously unresponsive dLGN neurons.    
It is important to acknowledge seemingly paradoxical reports that MPH 
dose-dependently decreases tonic output from the LC (Devilbiss and Berridge, 
2006).  As such, systemic administration of MPH would produce competing 
actions – blockade of NE reuptake resulting in elevated extracellular 
concentrations of transmitter versus reduced impulse activity along LC fibers and 
decreased NE release.  However, the results of microdialysis studies indicate 
that the net impact of blocking NE transporter uptake following systemic drug 
administration is increased extracellular levels of NE in noradrenergic terminal 
fields (Berridge et al., 2006, Bymaster et al., 2002, Drouin et al., 2006), resulting 
in the facilitation of stimulus-driven responses (Devilbiss and Berridge, 2008, 
Drouin et al., 2007).   
Overall, MPH administration produced characteristic NE-like modulation of 
sensory-driven neuronal responses in the dLGN.  MPH mimicked the effects of 
raising NE concentrations in sensory circuits by LC electrical stimulation as well 
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as direct local application of NE.  Therefore, the present results show that MPH 
optimizes early stage processing of sensory signals by decreasing response 
latency, increasing response magnitude, and gating previously unresponsive 
neurons into the sensory response pool in a fashion similar to that prompted by 
output from the intrinsic LC-NE system.   
 
MPH mimics attention-mediated modulation of sensory processing circuits 
 Many of the observed modulations of dLGN neuronal responsiveness and 
LFP activity by MPH also resemble the effects of top-down mediated changes in 
sensory signal processing that occur during states of arousal and sustained 
attention.  Studies examining the effects of selective attention on the processing 
of sensory stimuli have revealed top-down alterations in the timing and 
magnitudes of sensory responses as well.    
Selective attention has been shown to decrease the latency of stimulus 
evoked spike discharges as well as VEP responses within the visual cortex of 
monkeys performing a target detection task (Sundberg et al., 2012).  Response 
latencies were reduced by 1 – 2 msec when attention was directed to target 
stimuli as compared to non-target distractor stimuli, i.e. reductions that were 
similar to those observed within the dLGN of rats in the current work during task 
performance.  The authors suggested that attention decreases response 
latencies by producing a more depolarized state in neurons responsible for 
encoding target stimuli.  In such a case, the anticipation of target detection would 
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place the neurons closer to their detection or spiking threshold.  Although these 
effects were observed within the visual cortex of monkeys, these data suggest 
that MPH may be able to produce top-down-like effects on response latencies 
within more primary sensory processing regions of the brain during task 
performance.  
Attention-induced increases in response magnitudes have been reported 
in thalamic and cortical areas of monkeys and humans.  However, demonstrating 
attentional modulation has relied heavily on functional imaging, which may be a 
less precise measure of sensory activation as compared to unit spiking activity 
(Kastner and Pinsk, 2004, Kastner et al., 2006, O'Connor et al., 2002, Saalmann 
and Kastner, 2009, Schneider and Kastner, 2009).  Nonetheless, these studies 
were informative and produced evidence that the LGN is much more than a 
simple relay node, and instead may play a significant role in processing visual 
stimuli according to perceptual and cognitive demands.  Attentional modulation of 
single cell neuronal activity within the LGN was first demonstrated in monkeys by 
McAlonan and colleagues (2008).  These authors compared stimulus-evoked 
responses of both magnocellular and parvocellular LGN neurons to visual stimuli 
within each neuron’s receptive field when stimuli were attended versus 
unattended.  Attention increased the magnitude of evoked discharge in both 
types of neurons during task performance.  Attention has also been shown to 
increase the magnitude of cellular responses within the visual cortex of monkeys 
performing a visual target detection task (Sundberg et al., 2012).  Combined, 
these reports strongly suggest similarity between the effects of attention on the 
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magnitude of responses to visual targets in goal directed tasks and MPH 
modulation of visual responses to target stimuli within the dLGN of rats during 
performance of a visual signal detection task.  Further studies are warranted to 
investigate the potential for MPH to also enhance response magnitudes within 
higher visual cortical areas during task performance.   
 
Optimal LC output and attentional state 
MPH produces alterations in sensory processing within the rat dLGN that 
resemble modulatory effects previously described for NE within terminal fields 
and top-down prioritization of signals through attentional mechanisms.   For 
example, Sundberg et al. (2012) suggested that selective attention creates a 
depolarized state within sensory neurons in anticipation of task-relevant stimulus 
presentation.  Similarly, NE has been shown to exert a depolarizing effect on 
thalamic neurons in a slice preparation which alters their response to afferent 
inputs (Govindaiah and Cox, 2006b, McCormick and Prince, 1988).  The PFC 
regulates top-down attention to sensory stimuli according to behavioral 
relevance, especially during goal-directed and sensory-guided behaviors 
(Arnsten and Rubia, 2012, Arnsten and Pliszka, 2011).  The LC, which has also 
been implicated in regulating behavioral states of arousal and modulating state 
dependent processing of sensory information, is the primary source of NE to the 
PFC (Berridge and Waterhouse, 2003).  LC neurons are selectively activated in 
response to imperative stimuli during goal-directed behaviors and the strength of 
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phasic responses positively correlate with optimal behavioral performance 
(Aston-Jones and Cohen, 2005, Aston-Jones et al., 1997, Aston-Jones et al., 
1994).   Slight aberrations of the balance within the neurochemical environment 
of the PFC are strongly associated with impairments in executive functions such 
as attention, highlighting the importance of the LC’s noradrenergic projections to 
the PFC and the influence of NE on PFC-mediated behaviors (Arnsten and 
Rubia, 2012, Arnsten and Pliszka, 2011).   
A reciprocal connection also exists from the PFC to the LC and this may 
further strengthen the LC’s role in modulating sensory signal processing 
according to behavioral context (Arnsten and Goldman-Rakic, 1984, Bouret and 
Sara, 2004, Sesack et al., 1989).  PFC activation produces a prominent 
excitatory influence on the LC (Jodo et al., 1998).  These apparent circular 
influences suggest a mechanism whereby the PFC may signal how much NE is 
necessary for optimal executive operations according to behavioral state and 
contextual needs of the organism.  In this case, arousal states involving goal-
directed behavior would activate the PFC, which would in turn increase LC-NE 
output, thereby promoting a state of optimal preparedness for detecting 
behaviorally relevant stimuli within LC projection fields and ultimately resulting in 
the facilitation of sensory signal transmission in accord with behavioral demands.  
In other words, top-down modulation of sensory processing may require 
significant communication and cooperation between the PFC and LC-NE system 
in order to alter detection and discrimination of information necessary for 
adaptive responding.     
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Sensory enhancement is a significant component of psychostimulant-induced 
performance enhancement 
Previous studies have provided evidence that more efficient processing of 
visual information in the dLGN strengthens transmission of information to the 
visual cortex, thus facilitating higher order processing (Alonso et al., 1996, 
Saalmann and Kastner, 2009, Swadlow and Gusev, 2001).  Increased 
responsiveness and synchronous discharge of neurons responding to a given 
stimulus in the dLGN lead to higher probability of effectiveness in eliciting 
subsequent responses from cortical targets (Alonso et al., 1996).  This early 
stage augmentation of visual processing may lead to further improvements in 
cognition and general performance enhancement where attention to visual cues 
is necessary for favorable behavioral outcomes.  This facilitation may occur 
under normal circumstances as well as when cognitive and physical demands 
are high.  In line with this thinking, the current work suggests that MPH-induced 
enhancement of NE neurotransmission within primary sensory circuits such as 
the dLGN facilitates sensory signal processing and the resultant signal 
augmentation is a key component of the performance enhancing effects of 
psychostimulant drugs. 
Regarding the current work, MPH enhanced behavioral performance of 
the visual signal detection task.  In addition to faster and stronger sensory signal 
processing within the dLGN, MPH administration also led to faster reaction time 
latencies to make correct lever press responses during task performance.  These 
findings suggest that MPH enhances the efficiency of behavioral performance 
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during task engagement.  It is likely that faster and stronger transmission of 
sensory signals through the dLGN promote faster and stronger transmission to 
higher areas of information processing, decision making, and response planning.   
MPH-induced facilitation of dLGN responsiveness occurs at an early stage of 
information processing and could in turn speed and strengthen any further 
processing in higher order areas that receive information originating from within 
the dLGN, such as decision making processes and behavioral outcomes 
involving motor responses.  
Because MPH blocks reuptake of NE and DA, drug effects are possible 
throughout all noradrenergic and dopaminergic terminal fields.  As such, it is 
likely that MPH-induced facilitation of behavioral outcomes during the visual 
signal detection task involves multiple effects across sensory, cognitive, and 
motor networks in the brain.  In addition to the modulation of sensory processes 
described above, the LC-NE system broadly exerts its modulatory influence on 
multiple neural networks responsible for cognitive, sensory, and motor processes 
(Berridge and Waterhouse, 2003, Chandler et al., 2014).  Although the present 
work demonstrated that catecholaminergic innervation of the dLGN is solely 
noradrenergic, indicating that the enhancement of sensory signal processing 
observed within the dLGN is mediated by locally elevated NE levels, elevated DA 
levels likely contribute to MPH-induced performance enhancing effects through 
effects on brain regions outside of the dLGN.  Dopaminergic innervation is  
prominent throughout cognitive and motor networks that are necessary for 
mediating effective goal-directed performance and that would contribute to MPH-
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induced performance enhancing effects (Hosp and Luft, 2013, Lammel et al., 
2008).   
MPH raises NE and DA to optimal levels within the PFC at clinically 
relevant low doses prescribed for ADHD, an effect that induces a precisely 
balanced neurochemical environment for optimal operation of executive function 
(Arnsten and Rubia, 2012, Arnsten and Pliszka, 2011).  At these low doses, MPH 
preferentially increases DA and NE neurotransmission within the PFC and these 
effects strongly correspond with improved cognitive function (Berridge and 
Devilbiss, 2011, Devilbiss and Berridge, 2008).  As such, it is likely that MPH-
induced improvements in cognitive functions are due to enhanced 
catecholaminergic neurotransmission within the PFC.  PFC-mediated 
improvements in decision making processes relevant to sensory-guided and 
goal-directed performance may further benefit from faster and stronger 
transmission of sensory signals necessary for guiding performance at very early 
stages of sensory processing. 
Although considerably less work has been done to characterize NE-
mediated LC modulatory effects on motor systems, there are studies 
demonstrating that activation of noradrenergic mechanisms within motor circuits 
depolarizes motor neuron membrane resting potential and facilitates 
responsiveness to excitatory input (Heckman et al., 2009).  For example, it has 
been shown that application of NE decreased response thresholds and increased 
glutamate-evoked neuronal and field potential activity of spinal motor neurons 
(White and Neuman, 1980).  NE also enhances glutamate-evoked neuronal 
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responsiveness of trigeminal motor neurons (Schwarz and Peever, 2010).  
Similar to LC neuron activation in response to task-relevant sensory stimuli 
during goal-directed behaviors, the LC also exhibits prominent phasic responses 
immediately before initiation of task-relevant motor responses.  When monkeys 
performed a forced-choice discrimination task, phasic activation of LC neurons 
immediately preceded task-related behavioral responses (Clayton et al., 2004).  
In addition, faster LC response latencies to task-related stimuli corresponded to 
trials in which the animal made faster behavioral responses during performance 
(Rajkowski et al., 2004).  Together, these findings indicate that the LC may be 
heavily involved in goal-directed decision making processes and subsequent 
planning and execution of motor responses.  In addition to increasing the 
detection, discrimination, and transmission of task related sensory information 
target stimuli, a more global understanding of the LC system’s effects on 
downstream processing likely includes regulating the speed and strength of 
behavioral responses to task-relevant stimuli. 
 
Clinical significance 
The present work demonstrates the potential for psychostimulant agents 
to facilitate early stage sensory processing within the dLGN by increasing the 
speed of transmission and magnitude of response to visual stimuli.  In this 
regard, sensory enhancement appears to be a significant component of the 
performance enhancing effects of MPH.  Sensory enhancement likely represents 
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a major component of the overall drug effect desired across a broad range of 
users, including those with and without ADHD.   
 
Cognitive enhancement 
MPH is used as a pro-cognitive agent in healthy individuals (Cakic, 2009, 
Maher, 2008).  The effects demonstrated here in normal rats could translate to 
improved sensory function in normal individuals, thus providing at least one 
physiological explanation for off-label use of psychostimulant agents as cognitive 
enhancers.  When the range of pro-cognitive effects that have been observed in 
healthy individuals was recently reviewed, the most predominant and consistent 
effects of MPH were improvements in working memory, speed of processing, 
verbal learning and memory, attention/vigilance, and problem solving (Linssen et 
al., 2014).  It should be noted that many assays used to evaluate performance 
within these cognitive domains rely on sensory-guided tasks in response to visual 
stimuli.  As MPH enhances PFC dependent executive operations, it is likely that it 
simultaneously improves sensory attention and focus on visual signals necessary 
for cognitive performance.   
 
General performance enhancement 
MPH is also used as a general performance enhancing agent, especially 
in athletes for its physical benefits (Ambrose et al., 2013, Deventer et al., 2011, 
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Hickey and Fricker, 1999).  Psychostimulant use in athletes spans many sports, 
including cycling, basketball, football, cricket, hockey, and baseball.  Most sports 
governing agencies have developed strict policies regarding stimulant use and 
require a legitimate diagnosis of ADHD for a therapeutic use exemption, if they 
allow stimulant use at all.  One of the most surprising statistics is that major 
league baseball players are diagnosed with ADHD diagnosis at a frequency 2-3 
times that of the general adult population (Lakhan and Kirchgessner, 2012), a 
finding that suggests MPH malingering and misuse.  MPH-induced sensory 
enhancement in baseball players could create situations where a batter is able to 
more quickly process information and react to the speed and trajectory of a 
baseball that has just left the pitcher’s hand or an outfielder is better able to 
maintain focus on a fly ball as a visual target.  In such circumstances, reaction to 
target stimuli and behavioral performance would consequently improve as a 
function of enhanced sensory processing.  Although most reports would suggest 
that the major motivations of athletes to use psychostimulant drugs include 
improving concentration and motor coordination (Ambrose et al., 2013, Deventer 
et al., 2011, Hickey and Fricker, 1999), sensory enhancement is a strong 
contributing factor that has not been investigated as candidate for the desired 
effects produced by these drugs.   
 
171 
 
Recreational use 
The arousal-enhancing effects of MPH are the basis for its recreational 
use.  MPH elevates mood and induces a drug “rush” when ingested in higher 
concentrations than normally prescribed for cognitive enhancement in ADHD 
patients, promoting its use as a party drug both on and off college campuses 
(Lile et al., 2010).  When doses ingested exceed those of therapeutically-relevant 
concentrations, MPH begins to transition from a cognitive-enhancing, 
behaviorally-calming agent to a predominantly arousal-enhancing agent with 
abuse liability (Berridge and Arnsten, 2013).  In addition to producing reinforcing 
effects within arousal and reward circuits, amplification of sensory experiences 
also likely contributes to the ability of psychostimulants to further promote drug-
induced euphoria.  Heightened responses to sensory stimulation may introduce a 
new dimension of euphoria and drug-associated reinforcement that has not been 
previously considered.   
 
ADHD 
Abnormal regulation of sensory information processing is common to 
many neuropsychiatric disorders, including ADHD (Cheung and Siu, 2009, Clince 
et al., 2016, Koziol and Budding, 2012, Mangeot et al., 2001, Pfeiffer et al., 
2015).  The present work demonstrating MPH-induced enhancement of early 
stage sensory signal processing may represent an additional and previously 
unknown therapeutic effect of psychostimulant drugs.  Taken together, the ability 
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of MPH to enhance performance in tasks of attention, the impact of MPH on early 
sensory signal processing shown here, and the evidence that states of attention 
modulate LGN circuit function collectively point to early stage sensory signal 
processing as a prominent site of action for psychostimulant drugs.  The findings 
of the current study may seem counterintuitive in that amplification of sensory 
responsiveness may further exacerbate distractibility to all stimuli in the sensory 
surround irrespective of their behavioral relevance.  However, it is important to 
remember that the current work was conducted in normal animals and the 
pathology of ADHD may include factors that are not specific to the noradrenergic 
system.  It is possible that deficits in focus and concentration associated with 
ADHD pathology involves dysfunction of important complimentary mechanisms 
between modulatory neurotransmitters and top-down attentional forces that 
normally serve to amplify selective processing of salient or behaviorally-relevant 
sensory stimuli.  Imbalance of systems normally working in concert for optimal 
focus and concentration on imperative environmental stimuli may be responsible 
for sensory dysfunction associated with ADHD.  MPH produced enhancements in 
sensory processing that are reminiscent of both NE-mediated and attention-
mediated modulatory actions.  MPH may play a unique role in targeting 
mechanisms that normally bind these neuromodulatory influences, but are 
disconnected in ADHD.  Thus, MPH may be capable of alleviating sensory 
dysfunction associated with ADHD by strengthening the convergence and 
integration of these influences.  Overall, the results of the current work indicate 
that further efforts to elucidate the mechanisms by which attention-enhancing 
173 
 
medications influence early stage sensory processing may yield new insights 
regarding the pathophysiology of attention disorders and lead to development of 
improved therapeutic treatments.  
 
Theoretical model of noradrenergic effects during performance of the visual 
signal detection task 
In a simplified theoretical model, MPH-induced elevation of NE 
neurotransmission enhances the central representation and transmission of 
behaviorally-relevant sensory information, which in turn impacts executive 
function and behavioral outcomes (Figure 29).  States of arousal, vigilance, and 
optimal LC activity are fundamentally dependent on each other (Aston-Jones and 
Cohen, 2005, Berridge and Waterhouse, 2003).  Enhanced NE 
neurotransmission and selective attention to incoming stimuli amplify neuronal 
responses to sensory stimuli within the LGN (McAlonan et al., 2008, Rogawski 
and Aghajanian, 1980a).  MPH, by manipulating NE neurotransmission, 
bypasses yet also indirectly affects these internal state- and neurochemical-
dependent mechanisms to create optimal conditions for enhanced processing of 
sensory information.  Following MPH administration sensory information is 
transmitted to decision making circuits with greater speed and strength to result 
in more efficient behavioral responses as observed in the current experiments. 
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Figure 29.  Theoretical model of noradrenergic effects during performance 
of the visual signal detection task.  MPH-induced elevation of NE 
neurotransmission enhances sensory processing of behaviorally-relevant stimuli, 
an effect normally driven by states of arousal and optimal LC output.  Sensory 
enhancement then facilitates the speed and strength of signal transmission to 
areas of higher order information processing and behavioral outcomes.   
  
175 
 
Future directions 
The current work has shown that MPH enhances the speed and strength 
of signal transmission within the dLGN of rats during performance of a visual 
signal detection task.  MPH also improved reaction times to make correct 
responses within the task, indicating more efficient behavior.  All 
catecholaminergic axons within the dLGN are noradrenergic; signifying that the 
sensory enhancement observed within the dLGN is likely mediated locally by 
enhanced NE neurotransmission.  This work suggests sensory enhancement via 
noradrenergic mechanisms is a significant component of the performance 
enhancing effects of psychostimulant drugs and likely contributes to the drug’s 
clinical efficacy and off-label desirability.  These findings prompt new paths of 
inquiry to provide a full accounting of the actions of MPH on early stage sensory 
signal processing and impact on behavioral outcomes. 
 
Effects of methylphenidate behavioral accuracy 
The present results demonstrate that MPH improves behavioral efficiency 
by decreasing reaction times to make correct lever presses in a modified visual 
signal detection task.  However, there were no improvements in detection 
accuracy.  These results are in contrast with previous reports demonstrating 
MPH-induced improvements in response accuracy during performance of similar 
signal detection tasks (Bizarro et al., 2004, Navarra et al., 2008, Paterson et al., 
2011, Robinson, 2012).  The modified visual signal detection task used here 
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requires that animals initiate each trial by maintaining an observing response 
directly below light stimuli necessary for guiding performance.  In this version of 
the task, animals were always primed for stimulus presentation and ready to 
initiate a response.  Consequentially, animals highly trained in the modified visual 
signal detection task generally performed with greater than 90% accuracy and it 
is likely that their performance accuracy had already reached a ceiling that did 
not allow a sufficient therapeutic window for evaluating drug-induced alterations 
on this measure.  Previous studies reporting MPH-induced enhancements in 
performance accuracy examined drug actions on animals with sub-optimal 
performance as compared to high performers or employed paradigms with 
unpredictable increases in difficulty of signal detection on test days (Bizarro et 
al., 2004, Navarra et al., 2008, Paterson et al., 2011, Robinson, 2012).  It is likely 
that the modified visual signal detection task used here lacked the complexity to 
reveal drug-induced improvements in performance accuracy.  Future studies can 
offset “ceiling effects” resulting from task simplicity and evaluate effectively drug 
effects on accuracy by adding sensory distractors or lowering the contrast of 
target stimuli during task performance.  In a set of pilot studies using different 
stimulus light duration, differences in task accuracy and dLGN unit responding 
have been observed (Figure 21). 
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Local receptor-mediated actions of methylphenidate 
The present results also demonstrated that all catecholaminergic fibers 
within the rat dLGN are noradrenergic, suggesting that the local sensory 
enhancing effects observed following MPH administration are mediated through 
noradrenergic mechanisms within the dLGN.  This view is further supported by 
previous experiments demonstrating NE augmentation of dLGN neuronal 
responses to visual pathway stimulation via activation of alpha-1 postsynaptic 
adrenergic receptors (Rogawski and Aghajanian, 1980b, 1982).  However, 
indirect effects from circuits that are afferent to the dLGN cannot be definitively 
ruled out.  Although there was no evidence of dopamine fibers within the rat 
dLGN, enhanced dopaminergic transmission in areas upstream from the dLGN 
and capable of influencing dLGN function is also plausible as MPH blocks 
reuptake of both NE and DA (Han and Gu, 2006, Hannestad et al., 2010, 
Spencer et al., 2006, Volkow et al., 2002).  Local drug infusion studies could 
address issues regarding the consequences of effects that may be occurring 
remotely and/or the contribution of additional neuromodulatory systems, such as 
DA, that may influence neuronal responses.  Probes that combine extracellular 
recording electrodes with cannula for local infusion of agonists or antagonists 
have been used previously in this laboratory and elsewhere to investigate the 
actions of locally administered compounds (du Hoffmann et al., 2011).  In a pilot 
experiment designed to validate the use of infusion cannula equipped with 
recording electrodes, spontaneously active cells near the dLGN were recorded 
during simultaneous local infusion of lidocaine, a sodium channel blocker that 
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inhibits neural activity (du Hoffmann et al., 2011).  Lidocaine (0.55 µl of 4% 
lidocaine at a flow rate of 0.046µl/min) administration inhibited firing in 2 
simultaneously recorded neurons.  Activity was abolished for the duration of 
infusion (12 minutes) and then recovered shortly following the end of infusion.  A 
representative example is shown in Figure 30.  To further investigate the receptor 
mediated mechanisms responsible for sensory enhancement within the rat 
dLGN, experiments could be repeated with local administration of NE and DA 
receptor subtype specific agonists.      
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Figure 30.  Simultaneous recording with lidocaine injections near the 
dLGN.  Lidocaine (0.55µl of 4% lidocaine in saline administered at a flow rate of 
0.046µl/min) abolished activity of spontaneously-active cells near the dLGN for 
the duration of infusion (12 minutes, indicated by red bar).  Activity recovered 
shortly following the end of infusion.  Rate histograms calculated for 10s bins with 
boxcar smoothing over 3 adjacent bins.  
 
  
  
180 
 
Local versus systemic administration of methylphenidate 
The degree to which MPH-induced performance enhancement is 
dependent on enhanced sensory signal processing within the dLGN of rats 
performing a signal detection task has not been directly investigated in the 
present work.  MPH-induced decreases in dLGN response latencies to light 
stimuli were on the order of 1 – 3 msec, whereas decreases in behavioral 
response latencies during task performance were as much as 200 msec, which 
allows for considerable additional action and influence of MPH on intermediate 
mechanisms of information transfer and execution of behavioral outcome.  
However, small latency differences at very early stages of sensory signal 
processing have the potential to be of major functional importance throughout 
networks of signal processing, decision making, and effector action.  To 
dissociate the degree to which MPH-induced dLGN enhancement is dependent 
on or contributes to overall performance enhancement, MPH could be infused 
bilaterally in the dLGN of rats performing a visually guided behavioral task.  If 
local infusion of MPH enhances dLGN neuronal responses to target stimuli and 
improves behavioral performance as observed here, it could be argued that at 
least a component of psychostimulant-induced performance enhancing effects is 
dependent on augmentation of early stage of signal processing.  This strategy 
has in fact been employed to assess the effects regional vs systemic 
administration of MPH on PFC-dependent rodent behavior (Spencer et al., 2015).  
In those studies, locally administered MPH had effects similar to those resulting 
from systemic MPH administration.  Further analysis using this approach could 
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compare the effects of systemically-administered MPH versus local MPH infusion 
on electrophysiological and behavioral indices of performance and determine the 
degree of performance enhancement resulting from drug actions within dLGN 
and in networks outside of dLGN.   
 
Dependence of methylphenidate effects on behavioral relevance of sensory 
stimuli 
One final question that emerges from the results of the present work is 
whether MPH-induced enhancement of sensory signal processing is specific to 
task-related stimuli or due to a general enhancement of all sensory signals.  In 
the current experiments using a modified visual signal detection task, the light 
stimuli were behaviorally relevant and successful goal-directed performance 
within the task was contingent on indication of whether or not the stimulus light 
was detected. It would be of significant interest to include task relevant versus 
task irrelevant light stimuli in the experimental paradigm.  A primary question is 
whether MPH administration would enhance neural responsiveness to relevant 
stimuli, while decreasing responsiveness to irrelevant or distractor stimuli.  To 
evaluate the selectivity of MPH-induced sensory enhancement within the dLGN 
and possible suppression of irrelevant stimuli, a cross-modal signal detection 
task could be employed.  The cross-modal signal detection task would randomly 
present visual and auditory stimuli and rats would learn which stimulus was 
relevant and which was irrelevant in a given block of trials by feedback through 
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water rewards.  By requiring the animals to shift behavioral strategies according 
to cross-modal rule switches, light-evoked responses within the dLGN could be 
compared for visual stimuli that were relevant versus non-relevant.  It could then 
be determined if MPH-induced modulation of sensory driven responses was 
dependent on stimulus relevance defined by the requirements of behavioral 
outcome for successful goal-directed performance.  Such an experiment would 
provide further understanding of MPH-induced enhancement of early stage 
sensory signal processing and the neuromodulatory role of the LC-NE system on 
these processes during various physiological conditions.   
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